Ingredient ID 304 
Chinese Pronunciation CHANSU 
English Name Toad Venom  
Latin Name Venenum Bufonis  
Aliases ChanSuMeiZhi
Cancers Skin
Identified Compounds

order by name

1. Arenobufagin

   C24H32O6   416.51

2. Bufalin

   C24H34O4   386.53

3. Bufotalidin

   C24H32O6   416.51

4. Bufotalin

   C25H34O7   446.54

5. Bufotalinin

   C24H30O6   414.5

6. Bufotenidine

   C13H18N2O   218.3

7. Bufothionine

   C12H15N2O3S   267.33

8. Cholesterol

   C27H46O   386.66

9. Cinobufagin

   C26H34O6   442.55

10. Cinobufotalidin

   C24H34O6   418.52

11. Cinobufotalin

   C26H34O7   458.55

12. Bufotenine

   C12H16N2O   204.27

13. Cinobufotoxin

   C40H58N4O10   754.92

14. Desacetylbufotalin

   C24H34O5   402.53

15. Desacetylcinobufagin

   C24H32O5   400.51

16. Gamabufotalin

   C24H34O4   386.53

17. Resibufogenin

   C24H32O4   384.51

18. Suberic Acid

   C8H14O4   174.19

19. Telocinobufagin

   C24H34O5   402.53

20. 10beta-hydroxy-19-methyl-cinobufagin

   C26H34O7   458.54

21. 12-beta-hydroxycinobufagin

   C26H34O7   458.54

22. 15beta-hydroxy-bufalin

   C24H34O5   402.52

23. 19-hydroxycinobufotalin

   C26H34O8   475.54

24. 19-hydroxymarinobufagin

   C24H32O6   416.51

25. 19-oxdessacetyl-cinobufotalin


26. 19beta-hydroxybufalin

   C24H34O5   402.52

27. 3-(11-o-accetyl-gamabufotaly)suberic Acid


28. 3-arenobufagyl-suberic Acid


29. 3-bufolyl-suberic Acid


30. 3-bufotalyl-suberic Acid


31. 3-gamabufotalyl-suberic Acid


32. 3-resibufogenyl-suberic Acid


33. 4beta-hydroxybufalin

   C24H34O5   402.52

34. Adrenaline

   C9H13NO3   183.2

35. Bufotalon


36. Bufotoxin

   C40H60N4O10   756.93

37. Cinobufotenine

   C12H16N2O   204.27

38. Desacetylcinobufaginol

   C24H30O6   414.49

39. Resibufogin


40. Telocinobufagyl Suberic Acid


Recipes that contain
  1. 236      ZhiAiWan
  2. 257      AiNingQiHaoWan
  3. 268      ChangAiShuan
  4. 331      BiAiFang
  5. 378      AiLiuGao
  6. 380      QiXiaoWan
  7. 412      PiAiLing
  8. 419      WuHuDan
  9. 435      BaiXueBingFang
  10. 465      FuFangLuGanShiHu
  11. 469      TuoDuWan
  12. 469      TuoDuWan
  13. 474      GuLiuSan

Available references (order by impact factor):

1:  Leissring MA, Akbari Y, Fanger CM, Cahalan MD, Mattson MP, LaFerla FM.
Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice.
J Cell Biol.    impact factor:   12.88
2000;  149(4): 793-8

2:  Huang PS, Oliff A.
Drug-targeting strategies in cancer therapy.
Curr Opin Genet Dev.    impact factor:   12.665
2001;  11(1): 104-10

3:  Degen LP, Peng F, Collet A, Rossi L, Ketterer S, Serrano Y, Larsen F, Beglinger C, Hildebrand P.
Blockade of GRP receptors inhibits gastric emptying and gallbladder contraction but accelerates small intestinal transit.
Gastroenterology.    impact factor:   12.182
2001;  120(2): 361-8

4:  Bragado MJ, Groblewski GE, Williams JA.
Regulation of protein synthesis by cholecystokinin in rat pancreatic acini involves PHAS-I and the p70 S6 kinase pathway.
Gastroenterology.    impact factor:   12.182
1998;  115(3): 733-42

5:  Cho WK, Mennone A, Rydberg SA, Boyer JL.
Bombesin stimulates bicarbonate secretion from rat cholangiocytes: implications for neural regulation of bile secretion.
Gastroenterology.    impact factor:   12.182
1997;  113(1): 311-21

6:  Piiper A, Stryjek-Kaminska D, Klengel R, Zeuzem S.
Epidermal growth factor inhibits bombesin-induced activation of phospholipase C-beta1 in rat pancreatic acinar cells.
Gastroenterology.    impact factor:   12.182
1997;  113(5): 1747-55

7:  Sumitomo M, Shen R, Walburg M, Dai J, Geng Y, Navarro D, Boileau G, Papandreou CN, Giancotti FG, Knudsen B, Nanus DM.
Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling.
J Clin Invest.    impact factor:   10.921
2000;  106(11): 1399-407

8:  Sunday ME, Yoder BA, Cuttitta F, Haley KJ, Emanuel RL.
Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia.
J Clin Invest.    impact factor:   10.921
1998;  102(3): 584-94

9:  Seensalu R, Avedian D, Barbuti R, Song M, Slice L, Walsh JH.
Bombesin-induced gastrin release from canine G cells is stimulated by Ca2+ but not by protein kinase C, and is enhanced by disruption of rho/cytoskeletal pathways.
J Clin Invest.    impact factor:   10.921
1997;  100(5): 1037-46

10:  Ferris HA, Carroll RE, Rasenick MM, Benya RV.
Constitutive activation of the gastrin-releasing peptide receptor expressed by the nonmalignant human colon epithelial cell line NCM460.
J Clin Invest.    impact factor:   10.921
1997;  100(10): 2530-7

11:  Dockray GJ.
Gastrin-releasing peptide: an identity crisis at 30?
Lancet.    impact factor:   10.197
2001;  358(9284): 778-9

12:  Villalonga P, Lopez-Alcala C, Bosch M, Chiloeches A, Rocamora N, Gil J, Marais R, Marshall CJ, Bachs O, Agell N.
Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling.
Mol Cell Biol.    impact factor:   9.866
2001;  21(21): 7345-54

13:  Lee LF, Guan J, Qiu Y, Kung HJ.
Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
Mol Cell Biol.    impact factor:   9.866
2001;  21(24): 8385-97

14:  Boshans RL, Szanto S, van Aelst L, D'Souza-Schorey C.
ADP-ribosylation factor 6 regulates actin cytoskeleton remodeling in coordination with Rac1 and RhoA.
Mol Cell Biol.    impact factor:   9.866
2000;  20(10): 3685-94

15:  McArthur AJ, Coogan AN, Ajpru S, Sugden D, Biello SM, Piggins HD.
Gastrin-releasing peptide phase-shifts suprachiasmatic nuclei neuronal rhythms in vitro.
J Neurosci.    impact factor:   8.955
2000;  20(14): 5496-502

16:  Ohki-Hamazaki H, Sakai Y, Kamata K, Ogura H, Okuyama S, Watase K, Yamada K, Wada K.
Functional properties of two bombesin-like peptide receptors revealed by the analysis of mice lacking neuromedin B receptor.
J Neurosci.    impact factor:   8.955
1999;  19(3): 948-54

17:  Merali Z, McIntosh J, Kent P, Michaud D, Anisman H.
Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala.
J Neurosci.    impact factor:   8.955
1998;  18(12): 4758-66

18:  Zhou L, Zhang CL, Messing A, Chiu SY.
Temperature-sensitive neuromuscular transmission in Kv1.1 null mice: role of potassium channels under the myelin sheath in young nerves.
J Neurosci.    impact factor:   8.955
1998;  18(18): 7200-15

19:  Burdakov D, Galione A.
Two neuropeptides recruit different messenger pathways to evoke Ca2+ signals in the same cell.
Curr Biol.    impact factor:   8.733
2000;  10(16): 993-6

20:  Saurin JC, Fallavier M, Sordat B, Gevrey JC, Chayvialle JA, Abello J.
Bombesin stimulates invasion and migration of Isreco1 colon carcinoma cells in a Rho-dependent manner.
Cancer Res.    impact factor:   8.614
2002;  62(16): 4829-35

21:  Sumitomo M, Milowsky MI, Shen R, Navarro D, Dai J, Asano T, Hayakawa M, Nanus DM.
Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway.
Cancer Res.    impact factor:   8.614
2001;  61(8): 3294-8

22:  Sumitomo M, Shen R, Goldberg JS, Dai J, Navarro D, Nanus DM.
Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation.
Cancer Res.    impact factor:   8.614
2000;  60(23): 6590-6

23:  Saurin JC, Nemoz-Gaillard E, Sordat B, Cuber JC, Coy DH, Abello J, Chayvialle JA.
Bombesin stimulates adhesion, spreading, lamellipodia formation, and proliferation in the human colon carcinoma Isreco1 cell line.
Cancer Res.    impact factor:   8.614
1999;  59(4): 962-7

24:  Paolucci L, Rozengurt E.
Protein kinase D in small cell lung cancer cells: rapid activation through protein kinase C.
Cancer Res.    impact factor:   8.614
1999;  59(3): 572-7

25:  Cox ME, Deeble PD, Lakhani S, Parsons SJ.
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
Cancer Res.    impact factor:   8.614
1999;  59(15): 3821-30

26:  Xie Y, Gibbs TC, Mukhin YV, Meier KE.
Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells.
J Biol Chem.    impact factor:   7.666
2002;  277(36): 32516-26

27:  Zhukova E, Sinnett-Smith J, Rozengurt E.
Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells.
J Biol Chem.    impact factor:   7.666
2001;  276(43): 40298-305

28:  Rey O, Young SH, Cantrell D, Rozengurt E.
Rapid protein kinase D translocation in response to G protein-coupled receptor activation. Dependence on protein kinase C.
J Biol Chem.    impact factor:   7.666
2001;  276(35): 32616-26

29:  MacKinnon AC, Waters C, Jodrell D, Haslett C, Sethi T.
Bombesin and substance P analogues differentially regulate G-protein coupling to the bombesin receptor. Direct evidence for biased agonism.
J Biol Chem.    impact factor:   7.666
2001;  276(30): 28083-91

30:  Guo YS, Hellmich MR, Wen XD, Townsend CM Jr.
Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells.
J Biol Chem.    impact factor:   7.666
2001;  276(25): 22941-7

31:  Rey O, Sinnett-Smith J, Zhukova E, Rozengurt E.
Regulated nucleocytoplasmic transport of protein kinase D in response to G protein-coupled receptor activation.
J Biol Chem.    impact factor:   7.666
2001;  276(52): 49228-35

32:  Siegel G, Sternfeld L, Gonzalez A, Schulz I, Schmid A.
Arachidonic acid modulates the spatiotemporal characteristics of agonist-evoked Ca2+ waves in mouse pancreatic acinar cells.
J Biol Chem.    impact factor:   7.666
2001;  276(20): 16986-91

33:  Hueber AO, Zornig M, Bernard AM, Chautan M, Evan G.
A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts.
J Biol Chem.    impact factor:   7.666
2000;  275(14): 10453-62

34:  Hipkin RW, Wang Y, Schonbrunn A.
Protein kinase C activation stimulates the phosphorylation and internalization of the sst2A somatostatin receptor.
J Biol Chem.    impact factor:   7.666
2000;  275(8): 5591-9

35:  Yuan J, Slice L, Walsh JH, Rozengurt E.
Activation of protein kinase D by signaling through the alpha subunit of the heterotrimeric G protein G(q).
J Biol Chem.    impact factor:   7.666
2000;  275(3): 2157-64

36:  Sinnett-Smith J, Santiskulvong C, Duque J, Rozengurt E.
D-Arg(1),D-Trp(5,7,9),Leu(11)]Substance P inhibits bombesin-induced mitogenic signal transduction mediated by both G(q) and G(12) in Swiss 3T3cells.
J Biol Chem.    impact factor:   7.666
2000;  275(39): 30644-52

37:  Yang X, Rudolf M, Carew MA, Yoshida M, Nerreter V, Riley AM, Chung SK, Bruzik KS, Potter BV, Schultz C, Shears SB.
Inositol 1,3,4-trisphosphate acts in vivo as a specific regulator of cellular signaling by inositol 3,4,5,6-tetrakisphosphate.
J Biol Chem.    impact factor:   7.666
1999;  274(27): 18973-80

38:  Salazar EP, Rozengurt E.
Bombesin and platelet-derived growth factor induce association of endogenous focal adhesion kinase with Src in intact Swiss 3T3 cells.
J Biol Chem.    impact factor:   7.666
1999;  274(40): 28371-8

39:  Hellmich MR, Ives KL, Udupi V, Soloff MS, Greeley GH Jr, Christensen BN, Townsend CM Jr.
Multiple protein kinase pathways are involved in gastrin-releasing peptide receptor-regulated secretion.
J Biol Chem.    impact factor:   7.666
1999;  274(34): 23901-9

40:  Moore ED, Ring M, Scriven DR, Smith VC, Meloche RM, Buchan AM.
The role of protein kinase C isozymes in bombesin-stimulated gastrin release from human antral gastrin cells.
J Biol Chem.    impact factor:   7.666
1999;  274(32): 22493-501

41:  Rodriguez-Fernandez JL, Rozengurt E.
Bombesin, vasopressin, lysophosphatidic acid, and sphingosylphosphorylcholine induce focal adhesion kinase activation in intact Swiss 3T3 cells.
J Biol Chem.    impact factor:   7.666
1998;  273(30): 19321-8

42:  Macleod RJ, Lembessis P, James S, Bennett HP.
Isolation of a member of the neurotoxin/cytotoxin peptide family from Xenopus laevis skin which activates dihydropyridine-sensitive Ca2+ channels in mammalian epithelial cells.
J Biol Chem.    impact factor:   7.666
1998;  273(32): 20046-51

43:  Posern G, Weber CK, Rapp UR, Feller SM.
Activity of Rap1 is regulated by bombesin, cell adhesion, and cell density in NIH3T3 fibroblasts.
J Biol Chem.    impact factor:   7.666
1998;  273(38): 24297-300

44:  Little MJ, Zappia C, Gilles N, Connor M, Tyler MI, Martin-Eauclaire MF, Gordon D, Nicholson GM.
delta-Atracotoxins from australian funnel-web spiders compete with scorpion alpha-toxin binding but differentially modulate alkaloid toxin activation of voltage-gated sodium channels.
J Biol Chem.    impact factor:   7.666
1998;  273(42): 27076-83

45:  Ryan RR, Weber HC, Hou W, Sainz E, Mantey SA, Battey JF, Coy DH, Jensen RT.
Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
J Biol Chem.    impact factor:   7.666
1998;  273(22): 13613-24

46:  Pettitt TR, Martin A, Horton T, Liossis C, Lord JM, Wakelam MJ.
Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions. Phospholipase D-derived diacylglycerol does not activate protein kinase C in porcine aortic endothelial cells.
J Biol Chem.    impact factor:   7.666
1997;  272(28): 17354-9

47:  Akeson M, Sainz E, Mantey SA, Jensen RT, Battey JF.
Identification of four amino acids in the gastrin-releasing peptide receptor that are required for high affinity agonist binding.
J Biol Chem.    impact factor:   7.666
1997;  272(28): 17405-9

48:  Zugaza JL, Waldron RT, Sinnett-Smith J, Rozengurt E.
Bombesin, vasopressin, endothelin, bradykinin, and platelet-derived growth factor rapidly activate protein kinase D through a protein kinase C-dependent signal transduction pathway.
J Biol Chem.    impact factor:   7.666
1997;  272(38): 23952-60

49:  Casamassima A, Rozengurt E.
Tyrosine phosphorylation of p130(cas) by bombesin, lysophosphatidic acid, phorbol esters, and platelet-derived growth factor. Signaling pathways and formation of a p130(cas)-Crk complex.
J Biol Chem.    impact factor:   7.666
1997;  272(14): 9363-70

50:  Yan Y, Chi PP, Bourne HR.
RGS4 inhibits Gq-mediated activation of mitogen-activated protein kinase and phosphoinositide synthesis.
J Biol Chem.    impact factor:   7.666
1997;  272(18): 11924-7

51:  Mantey SA, Weber HC, Sainz E, Akeson M, Ryan RR, Pradhan TK, Searles RP, Spindel ER, Battey JF, Coy DH, Jensen RT.
Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.
J Biol Chem.    impact factor:   7.666
1997;  272(41): 26062-71

52:  Short SM, Talbott GA, Juliano RL.
Integrin-mediated signaling events in human endothelial cells.
Mol Biol Cell.    impact factor:   7.527
1998;  9(8): 1969-80

53:  Thimister PW, Hopman WP, Tangerman A, Rosenbusch G, Willems HL, Jansen JB.
Effect of intraduodenal bile salt on pancreaticobiliary responses to bombesin and to cholecystokinin in humans.
Hepatology.    impact factor:   7.344
1998;  28(6): 1454-60

54:  Posern G, Rapp UR, Feller SM.
The Crk signaling pathway contributes to the bombesin-induced activation of the small GTPase Rap1 in Swiss 3T3 cells.
Oncogene.    impact factor:   6.517
2000;  19(54): 6361-8

55:  Kiaris H, Schally AV, Sun B, Armatis P, Groot K.
Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.
Oncogene.    impact factor:   6.517
1999;  18(50): 7168-73

56:  Charlesworth A, Rozengurt E.
Bombesin and neuromedin B stimulate the activation of p42(mapk) and p74(raf-1) via a protein kinase C-independent pathway in Rat-1 cells.
Oncogene.    impact factor:   6.517
1997;  14(19): 2323-9

57:  Hong SS, Galaup A, Peytavi R, Chazal N, Boulanger P.
Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificity.
Hum Gene Ther.    impact factor:   6.403
1999;  10(16): 2577-86

58:  Pansky A, De Weerth A, Fasler-Kan E, Boulay JL, Schulz M, Ketterer S, Selck C, Beglinger C, Von Schrenck T, Hildebrand P.
Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma.
J Am Soc Nephrol.    impact factor:   6.182
2000;  11(8): 1409-18

59:  Beales IL.
Regulation of gastric function by gastrin releasing peptide.
Gut.    impact factor:   5.748
2002;  50(6): 897-8; discussion 898

60:  Hildebrand P, Lehmann FS, Ketterer S, Christ AD, Stingelin T, Beltinger J, Gibbons AH, Coy DH, Calam J, Larsen F, Beglinger C.
Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist.
Gut.    impact factor:   5.748
2001;  49(1): 23-8

61:  DeWitt RC, Wu Y, Renegar KB, King BK, Li J, Kudsk KA.
Bombesin recovers gut-associated lymphoid tissue and preserves immunity to bacterial pneumonia in mice receiving total parenteral nutrition.
Ann Surg.    impact factor:   5.647
2000;  231(1): 1-8

62:  Sklenicka HM, Hsung RP, McLaughlin MJ, Wei LL, Gerasyuto AI, Brennessel WB.
Stereoselective formal [3 + 3] cycloaddition approach to cis-1-azadecalins and synthesis of (-)-4a,8a-diepi-pumiliotoxin C. evidence for the first highly stereoselective 6pi-electron electrocyclic ring closures of 1-azatrienes.
J Am Chem Soc.    impact factor:   5.537
2002;  124(35): 10435-42

63:  Cullen A, Van Marter LJ, Allred EN, Moore M, Parad RB, Sunday ME.
Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia.
Am J Respir Crit Care Med.    impact factor:   5.491
2002;  165(8): 1093-7

64:  Cohen AJ, King TE Jr, Gilman LB, Magill-Solc C, Miller YE.
High expression of neutral endopeptidase in idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells.
Am J Respir Crit Care Med.    impact factor:   5.491
1998;  158(5 Pt 1): 1593-9

65:  Siegfried JM, DeMichele MA, Hunt JD, Davis AG, Vohra KP, Pilewski JM.
Expression of mRNA for gastrin-releasing peptide receptor by human bronchial epithelial cells. Association with prolonged tobacco exposure and responsiveness to bombesin-like peptides.
Am J Respir Crit Care Med.    impact factor:   5.491
1997;  156(2 Pt 1): 358-66

66:  Ebersole BJ, Visiers I, Weinstein H, Sealfon SC.
Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy.
Mol Pharmacol.    impact factor:   5.465
2003;  63(1): 36-43

67:  Li HL, Hadid D, Ragsdale DS.
The batrachotoxin receptor on the voltage-gated sodium channel is guarded by the channel activation gate.
Mol Pharmacol.    impact factor:   5.465
2002;  61(4): 905-12

68:  Wang SY, Barile M, Wang GK.
Disparate role of Na(+) channel D2-S6 residues in batrachotoxin and local anesthetic action.
Mol Pharmacol.    impact factor:   5.465
2001;  59(5): 1100-7

69:  Gallagher MJ, Chiara DC, Cohen JB.
Interactions between 3-(Trifluoromethyl)-3-(m-[(125)I]iodophenyl)diazirine and tetracaine, phencyclidine, or histrionicotoxin in the Torpedo series nicotinic acetylcholine receptor ion channel.
Mol Pharmacol.    impact factor:   5.465
2001;  59(6): 1514-22

70:  Wang SY, Barile M, Wang GK.
A phenylalanine residue at segment D3-S6 in Nav1.4 voltage-gated Na(+) channels is critical for pyrethroid action.
Mol Pharmacol.    impact factor:   5.465
2001;  60(3): 620-8

71:  Nau C, Wang SY, Strichartz GR, Wang GK.
Point mutations at N434 in D1-S6 of mu1 Na(+) channels modulate binding affinity and stereoselectivity of local anesthetic enantiomers.
Mol Pharmacol.    impact factor:   5.465
1999;  56(2): 404-13

72:  Williams BY, Dion SB, Schonbrunn A.
Role of receptor and protein kinase C activation in the internalization of the gastrin-releasing peptide receptor.
Mol Pharmacol.    impact factor:   5.465
1998;  54(5): 889-98

73:  Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, Clarke WP.
Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.
Mol Pharmacol.    impact factor:   5.465
1998;  54(1): 94-104

74:  Wang GK, Quan C, Wang SY.
Local anesthetic block of batrachotoxin-resistant muscle Na+ channels.
Mol Pharmacol.    impact factor:   5.465
1998;  54(2): 389-96

75:  Roth BL, Shoham M, Choudhary MS, Khan N.
Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors.
Mol Pharmacol.    impact factor:   5.465
1997;  52(2): 259-66

76:  Schofl C, Mader T, Kramer C, Waring M, Krippeit-Drews P, Prank K, von zur Muhlen A, Drews G, Brabant G.
Ca2+/calmodulin inhibition and phospholipase C-linked Ca2+ Signaling in clonal beta-cells.
Endocrinology.    impact factor:   5.365
1999;  140(12): 5516-23

77:  Pantanowitz L.
Drug-induced hyperkalemia.
Am J Med.    impact factor:   4.977
2002;  112(4): 334-5

78:  Suh BC, Kim JS, Namgung U, Han S, Kim KT.
Selective inhibition of beta(2)-adrenergic receptor-mediated cAMP generation by activation of the P2Y(2) receptor in mouse pineal gland tumor cells.
J Neurochem.    impact factor:   4.906
2001;  77(6): 1475-85

79:  Singh IN, Sorrentino G, Kanfer JN.
Amyloid beta protein (25-35) stimulation of phospholipase C in LA-N-2 cells.
J Neurochem.    impact factor:   4.906
1997;  69(1): 252-8

80:  Olincy A, Leonard S, Young DA, Sullivan B, Freedman R.
Decreased bombesin peptide response to cigarette smoking in schizophrenia.
Neuropsychopharmacology.    impact factor:   4.858
1999;  20(1): 52-9

81:  Wang SY, Nau C, Wang GK.
Residues in Na(+) channel D3-S6 segment modulate both batrachotoxin and local anesthetic affinities.
Biophys J.    impact factor:   4.58
2000;  79(3): 1379-87

82:  Vedantham V, Cannon SC.
Rapid and slow voltage-dependent conformational changes in segment IVS6 of voltage-gated Na(+) channels.
Biophys J.    impact factor:   4.58
2000;  78(6): 2943-58

83:  Mozsolits H, Lee TH, Wirth HJ, Perlmutter P, Aguilar MI.
The interaction of bioactive peptides with an immobilized phosphatidylcholine monolayer.
Biophys J.    impact factor:   4.58
1999;  77(3): 1428-44

84:  Wang SY, Wang GK.
Batrachotoxin-resistant Na+ channels derived from point mutations in transmembrane segment D4-S6.
Biophys J.    impact factor:   4.58
1999;  76(6): 3141-9

85:  Haselmann KF, Budnik BA, Olsen JV, Nielsen ML, Reis CA, Clausen H, Johnsen AH, Zubarev RA.
Advantages of external accumulation for electron capture dissociation in Fourier transform mass spectrometry.
Anal Chem.    impact factor:   4.555
2001;  73(13): 2998-3005

86:  Hearn MT, Zhao G.
Investigations into the thermodynamics of polypeptide interaction with nonpolar ligands.
Anal Chem.    impact factor:   4.555
1999;  71(21): 4874-85

87:  Salih B, Zenobi R.
MALDI mass spectrometry of dye-peptide and dye-protein complexes.
Anal Chem.    impact factor:   4.555
1998;  70(8): 1536-43

88:  Lennon JD 3rd, Glish GL.
A MALDI probe for mass spectrometers.
Anal Chem.    impact factor:   4.555
1997;  69(13): 2525-9

89:  Liu J, Lao ZJ, Zhang J, Schaeffer MT, Jiang MM, Guan XM, Van der Ploeg LH, Fong TM.
Molecular basis of the pharmacological difference between rat and human bombesin receptor subtype-3 (BRS-3).
Biochemistry.    impact factor:   4.493
2002;  41(28): 8954-60

90:  Katsuno T, Pradhan TK, Ryan RR, Mantey SA, Hou W, Donohue PJ, Akeson MA, Spindel ER, Battey JF, Coy DH, Jensen RT.
Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R).
Biochemistry.    impact factor:   4.493
1999;  38(22): 7307-20

91:  Hann RM, Pagan OR, Gregory LM, Jacome T, Eterovic VA.
The 9-arginine residue of alpha-conotoxin GI is responsible for its selective high affinity for the alphagamma agonist site on the electric organ acetylcholine receptor.
Biochemistry.    impact factor:   4.493
1997;  36(29): 9051-6

92:  Nemoz-Gaillard E, Cordier-Bussat M, Filloux C, Cuber JC, Van Obberghen E, Chayvialle JA, Abello J.
Bombesin stimulates cholecystokinin secretion through mitogen-activated protein-kinase-dependent and -independent mechanisms in the enteroendocrine STC-1 cell line.
Biochem J.    impact factor:   4.349
1998;  331 ( Pt 1): 129-35

93:  Miyakawa T, Kojima M, Ui M.
Differential routes of Ca2+ influx in Swiss 3T3 fibroblasts in response to receptor stimulation.
Biochem J.    impact factor:   4.349
1998;  329 ( Pt 1): 107-14

94:  Nicholson RA, Zheng J, Ganellin CR, Verdon B, Lees G.
Anesthetic-like interaction of the sleep-inducing lipid oleamide with voltage-gated sodium channels in mammalian brain.
Anesthesiology.    impact factor:   4.265
2001;  94(1): 120-8

95:  Ratnakumari L, Hemmings HC Jr.
Inhibition of presynaptic sodium channels by halothane.
Anesthesiology.    impact factor:   4.265
1998;  88(4): 1043-54

96:  Achilefu S, Jimenez HN, Dorshow RB, Bugaj JE, Webb EG, Wilhelm RR, Rajagopalan R, Johler J, Erion JL.
Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.
J Med Chem.    impact factor:   4.079
2002;  45(10): 2003-15

97:  Vamecq J, Bac P, Herrenknecht C, Maurois P, Delcourt P, Stables JP.
Synthesis and anticonvulsant and neurotoxic properties of substituted N-phenyl derivatives of the phthalimide pharmacophore.
J Med Chem.    impact factor:   4.079
2000;  43(7): 1311-9

98:  Cristau M, Devin C, Oiry C, Chaloin O, Amblard M, Bernad N, Heitz A, Fehrentz JA, Martinez J.
Synthesis and biological evaluation of bombesin constrained analogues.
J Med Chem.    impact factor:   4.079
2000;  43(12): 2356-61

99:  Vamecq J, Lambert D, Poupaert JH, Masereel B, Stables JP.
Anticonvulsant activity and interactions with neuronal voltage-dependent sodium channel of analogues of ameltolide.
J Med Chem.    impact factor:   4.079
1998;  41(18): 3307-13

100:  Gilon C, Huenges M, Matha B, Gellerman G, Hornik V, Afargan M, Amitay O, Ziv O, Feller E, Gamliel A, Shohat D, Wanger M, Arad O, Kessler H.
A backbone-cyclic, receptor 5-selective somatostatin analogue: synthesis, bioactivity, and nuclear magnetic resonance conformational analysis.
J Med Chem.    impact factor:   4.079
1998;  41(6): 919-29

101:  Ullstrom M, Parker D, Svensson E, Grillner S.
Neuropeptide-mediated facilitation and inhibition of sensory inputs and spinal cord reflexes in the lamprey.
J Neurophysiol.    impact factor:   3.935
1999;  81(4): 1730-40

102:  Maggi CA, Giuliani S, Zagorodnyuk V.
Sequential activation of the triple excitatory transmission to the circular muscle of guinea-pig colon.
Neuroscience.    impact factor:   3.924
1997;  79(1): 263-74

103:  Berg KA, Cropper JD, Niswender CM, Sanders-Bush E, Emeson RB, Clarke WP.
RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
Br J Pharmacol.    impact factor:   3.722
2001;  134(2): 386-92

104:  Chidlow G, Melena J, Osborne NN.
Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.
Br J Pharmacol.    impact factor:   3.722
2000;  130(4): 759-66

105:  Held HD, Martin C, Uhlig S.
Characterization of airway and vascular responses in murine lungs.
Br J Pharmacol.    impact factor:   3.722
1999;  126(5): 1191-9

106:  Beltran B, Barrachina MD, Mendez A, Quintero E, Esplugues JV.
Synthesis of nitric oxide in the dorsal motor nucleus of the vagus mediates the inhibition of gastric acid secretion by central bombesin.
Br J Pharmacol.    impact factor:   3.722
1999;  127(7): 1603-10

107:  Patacchini R, Bartho L, Maggi CA.
Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
Br J Pharmacol.    impact factor:   3.722
1997;  122(8): 1633-8

108:  Figini M, Emanueli C, Bertrand C, Sicuteri R, Regoli D, Geppetti P.
Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
Br J Pharmacol.    impact factor:   3.722
1997;  121(4): 773-81

109:  Qu X, Xiao D, Weber HC.
Human gastrin-releasing peptide receptor mediates sustained CREB phosphorylation and transactivation in HuTu 80 duodenal cancer cells.
FEBS Lett.    impact factor:   3.72
2002;  527(1-3): 109-13

110:  Ohinata K, Inui A, Asakawa A, Wada K, Wada E, Yoshikawa M.
Proadrenomedullin N-terminal 20 peptide (PAMP) elevates blood glucose levels via bombesin receptor in mice.
FEBS Lett.    impact factor:   3.72
2000;  473(2): 207-11

111:  Little MJ, Wilson H, Zappia C, Cestele S, Tyler MI, Martin-Eauclaire MF, Gordon D, Nicholson GM.
Delta-atracotoxins from Australian funnel-web spiders compete with scorpion alpha-toxin binding on both rat brain and insect sodium channels.
FEBS Lett.    impact factor:   3.72
1998;  439(3): 246-52

112:  Kiss Z, Crilly KS, Tomono M.
Bombesin and zinc enhance the synergistic mitogenic effects of insulin and phosphocholine by a MAP kinase-dependent mechanism in Swiss 3T3 cells.
FEBS Lett.    impact factor:   3.72
1997;  415(1): 71-4

113:  Cho WK, Boyer JL.
Characterization of ion transport mechanisms involved in bombesin-stimulated biliary secretion in rat cholangiocytes.
J Hepatol.    impact factor:   3.705
1999;  30(6): 1045-51

114:  Salido M, Vilches J, Lopez A, Roomans GM.
Neuropeptides bombesin and calcitonin inhibit apoptosis-related elemental changes in prostate carcinoma cell lines.
Cancer.    impact factor:   3.632
2002;  94(2): 368-77

115:  Kahan Z, Sun B, Schally AV, Arencibia JM, Cai RZ, Groot K, Halmos G.
Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
Cancer.    impact factor:   3.632
2000;  88(6): 1384-92

116:  Jungwirth A, Schally AV, Halmos G, Groot K, Szepeshazi K, Pinski J, Armatis P.
Inhibition of the growth of Caki-I human renal adenocarcinoma in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II.
Cancer.    impact factor:   3.632
1998;  82(5): 909-17

117:  Koppan M, Halmos G, Arencibia JM, Lamharzi N, Schally AV.
Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.
Cancer.    impact factor:   3.632
1998;  83(7): 1335-43

118:  Rogers BE, Curiel DT, Mayo MS, Laffoon KK, Bright SJ, Buchsbaum DJ.
Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vector.
Cancer.    impact factor:   3.632
1997;  80(12 Suppl): 2419-24

119:  Safavy A, Khazaeli MB, Qin H, Buchsbaum DJ.
Synthesis of bombesin analogues for radiolabeling with rhenium-188.
Cancer.    impact factor:   3.632
1997;  80(12 Suppl): 2354-9

120:  Plonowski A, Nagy A, Schally AV, Sun B, Groot K, Halmos G.
In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215.
Int J Cancer.    impact factor:   3.545
2000;  88(4): 652-7

121:  Breeman WA, De Jong M, Bernard BF, Kwekkeboom DJ, Srinivasan A, van der Pluijm ME, Hofland LJ, Visser TJ, Krenning EP.
Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy.
Int J Cancer.    impact factor:   3.545
1999;  83(5): 657-63

122:  Breeman WA, Hofland LJ, de Jong M, Bernard BF, Srinivasan A, Kwekkeboom DJ, Visser TJ, Krenning EP.
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy.
Int J Cancer.    impact factor:   3.545
1999;  81(4): 658-65

123:  Festuccia C, Guerra F, D'Ascenzo S, Giunciuglio D, Albini A, Bologna M.
In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin.
Int J Cancer.    impact factor:   3.545
1998;  75(3): 418-31

124:  Aprikian AG, Tremblay L, Han K, Chevalier S.
Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins.
Int J Cancer.    impact factor:   3.545
1997;  72(3): 498-504

125:  Douziech N, Calvo E, Laine J, Morisset J.
Activation of MAP kinases in growth responsive pancreatic cancer cells.
Cell Signal.    impact factor:   3.509
1999;  11(8): 591-602

126:  Santiskulvong C, Sinnett-Smith J, Rozengurt E.
EGF receptor function is required in late G(1) for cell cycle progression induced by bombesin and bradykinin.
Am J Physiol Cell Physiol.    impact factor:   3.485
2001;  281(3): C886-98

127:  Kim HJ, Evers BM, Litvak DA, Hellmich MR, Townsend CM Jr.
Signaling mechanisms regulating bombesin-mediated AP-1 gene induction in the human gastric cancer SIIA.
Am J Physiol Cell Physiol.    impact factor:   3.485
2000;  279(2): C326-34

128:  Lunn JA, Wong H, Rozengurt E, Walsh JH.
Requirement of cortical actin organization for bombesin, endothelin, and EGF receptor internalization.
Am J Physiol Cell Physiol.    impact factor:   3.485
2000;  279(6): C2019-27

129:  Smith CJ, Holmes AB, Press NJ.
The total synthesis of alkaloids (-)-histrionicotoxin 259A, 285C and 285E.
Chem Commun (Camb).    impact factor:   3.477
2002;  (11): 1214-5

130:  Reubi JC, Wenger S, Schmuckli-Maurer J, Schaer JC, Gugger M.
Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
Clin Cancer Res.    impact factor:   3.442
2002;  8(4): 1139-46

131:  Rosenfeld ME, Rogers BE, Khazaeli MB, Mikheeva G, Raben D, Mayo MS, Curiel DT, Buchsbaum DJ.
Adenoviral-mediated delivery of gastrin-releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo.
Clin Cancer Res.    impact factor:   3.442
1997;  3(7): 1187-94

132:  Aoyagi S, Hirashima S, Saito K, Kibayashi C.
Convergent approach to pumiliotoxin alkaloids. Asymmetric total synthesis of (+)-pumiliotoxins A, B, and 225F.
J Org Chem.    impact factor:   3.44
2002;  67(16): 5517-26

133:  Revial G, Jabin I, Lim S, Pfau M.
Aromatization of 1,6,7,7a-tetrahydro-2H-indol-2-ones by a novel process. Preparation of key-intermediate methyl 1-benzyl-5-methoxy-1H-indole-3-acetate and the syntheses of serotonin, melatonin, and bufotenin.
J Org Chem.    impact factor:   3.44
2002;  67(7): 2252-6

134:  Pearson WH, Fang W.
Synthesis of benzo-fused 1-azabicyclo[m.n.0]alkanes via the Schmidt reaction: a formal synthesis of gephyrotoxin.
J Org Chem.    impact factor:   3.44
2000;  65(21): 7158-74

135:  Bozem M, Kuhlmann S, Blum R, Feick P, Schulz I.
Hormone-stimulated calcium release is inhibited by cytoskeleton-disrupting toxins in AR4-2J cells.
Cell Calcium.    impact factor:   3.438
2000;  28(2): 73-82

136:  Xu X, Zeng W, Diaz J, Lau KS, Gukovskaya AC, Brown RJ, Pandol SJ, Muallem S.
nNOS and Ca2+ influx in rat pancreatic acinar and submandibular salivary gland cells.
Cell Calcium.    impact factor:   3.438
1997;  22(3): 217-28

137:  Gibson GE, Vestling M, Zhang H, Szolosi S, Alkon D, Lannfelt L, Gandy S, Cowburn RF.
Abnormalities in Alzheimer's disease fibroblasts bearing the APP670/671 mutation.
Neurobiol Aging.    impact factor:   3.399
1997;  18(6): 573-80

138:  McLaughlin MJ, Hsung RP, Cole KP, Hahn JM, Wang J.
A novel and highly stereoselective approach to aza-spirocycles. A short total synthesis of 2-epi-(+/-)-perhydrohistrionicotoxin and an unprecedented decarboxylation of 2-pyrones.
Org Lett.    impact factor:   3.367
2002;  4(12): 2017-20

139:  Gaunt MJ, Spencer JB.
Derailing the Wacker oxidation: development of a palladium-catalyzed amidation reaction.
Org Lett.    impact factor:   3.367
2001;  3(1): 25-8

140:  Uchikoba T, Mase T, Arima K, Yonezawa H, Kaneda M.
Isolation and characterization of a trypsin-like protease from Trichoderma viride.
Biol Chem.    impact factor:   3.356
2001;  382(10): 1509-13

141:  Schulz I, Krause E, Gonzalez A, Gobel A, Sternfeld L, Schmid A.
Agonist-stimulated pathways of calcium signaling in pancreatic acinar cells.
Biol Chem.    impact factor:   3.356
1999;  380(7-8): 903-8

142:  Rogers BE, Rosenfeld ME, Khazaeli MB, Mikheeva G, Stackhouse MA, Liu T, Curiel DT, Buchsbaum DJ.
Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer.
J Nucl Med.    impact factor:   3.326
1997;  38(8): 1221-9

143:  Vandermeers-Piret MC, Vandermeers A, Gourlet P, Ali MH, Waelbroeck M, Robberecht P.
Evidence that the lizard helospectin peptides are O-glycosylated.
Eur J Biochem.    impact factor:   3.307
2000;  267(14): 4556-60

144:  Lin Y, Jian X, Lin Z, Kroog GS, Mantey S, Jensen RT, Battey J, Northup J.
Two amino acids in the sixth transmembrane segment of the mouse gastrin-releasing peptide receptor are important for receptor activation.
J Pharmacol Exp Ther.    impact factor:   3.3
2000;  294(3): 1053-62

145:  Weiser T, Brenner M, Palluk R, Bechtel WD, Ceci A, Brambilla A, Ensinger HA, Sagrada A, Wienrich M.
BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.
J Pharmacol Exp Ther.    impact factor:   3.3
1999;  289(3): 1343-9

146:  Roman FJ, Lanet S, Hamon J, Brunelle G, Maurin A, Champeroux P, Richard S, Alessandri N, Gola M.
Pharmacological properties of trimebutine and N-monodesmethyltrimebutine.
J Pharmacol Exp Ther.    impact factor:   3.3
1999;  289(3): 1391-7

147:  Ryan RR, Weber HC, Mantey SA, Hou W, Hilburger ME, Pradhan TK, Coy DH, Jensen RT.
Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells.
J Pharmacol Exp Ther.    impact factor:   3.3
1998;  287(1): 366-80

148:  Naze S, Le Stunff H, Dokhac L, Thomas G, Harbon S.
Activation of phospholipase D by endothelin-1 in rat myometrium. Role of calcium and protein kinase C.
J Pharmacol Exp Ther.    impact factor:   3.3
1997;  281(1): 15-23

149:  Szereday Z, Schally AV, Nagy A, Plonowski A, Bajo AM, Halmos G, Szepeshazi K, Groot K.
Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215.
Br J Cancer.    impact factor:   3.282
2002;  86(8): 1322-7

150:  Chatzistamou I, Schally AV, Sun B, Armatis P, Szepeshazi K.
Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists.
Br J Cancer.    impact factor:   3.282
2000;  83(7): 906-13

151:  Burns DM, Walker B, Gray J, Nelson J.
Breast cancer cell-associated endopeptidase EC 24.11 modulates proliferative response to bombesin.
Br J Cancer.    impact factor:   3.282
1999;  79(2): 214-20

152:  Kiaris H, Schally AV, Nagy A, Sun B, Armatis P, Szepeshazi K.
Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice.
Br J Cancer.    impact factor:   3.282
1999;  81(6): 966-71

153:  Festuccia C, Angelucci A, Gravina G, Eleuterio E, Vicentini C, Bologna M.
Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement.
Exp Cell Res.    impact factor:   3.256
2002;  280(1): 1-11

154:  Sinnett-Smith J, Lunn JA, Leopoldt D, Rozengurt E.
Y-27632, an inhibitor of Rho-associated kinases, prevents tyrosine phosphorylation of focal adhesion kinase and paxillin induced by bombesin: dissociation from tyrosine phosphorylation of p130(CAS).
Exp Cell Res.    impact factor:   3.256
2001;  266(2): 292-302

155:  Fukai F, Mashimo M, Akiyama K, Goto T, Tanuma S, Katayama T.
Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide.
Exp Cell Res.    impact factor:   3.256
1998;  242(1): 92-9

156:  Li J, Hellmich MR, Greeley GH Jr, Townsend CM Jr, Evers BM.
Phorbol ester-mediated neurotensin secretion is dependent on the PKC-alpha and -delta isoforms.
Am J Physiol Gastrointest Liver Physiol.    impact factor:   3.228
2002;  283(5): G1197-206

157:  Kimura S, Mieno H, Tamaki K, Inoue M, Chayama K.
Nonselective cation channel as a Ca(2+) influx pathway in pepsinogen-secreting cells of bullfrog esophagus.
Am J Physiol Gastrointest Liver Physiol.    impact factor:   3.228
2001;  281(2): G333-41

158:  Murthy KS, Grider JR, Kuemmerle JF, Makhlouf GM.
Sustained muscle contraction induced by agonists, growth factors, and Ca(2+) mediated by distinct PKC isozymes.
Am J Physiol Gastrointest Liver Physiol.    impact factor:   3.228
2000;  279(1): G201-10

159:  Bonifacio MJ, Sheridan RD, Parada A, Cunha RA, Patmore L, Soares-da-Silva P.
Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine.
Epilepsia.    impact factor:   3.218
2001;  42(5): 600-8

160:  Kent P, Anisman H, Merali Z.
Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin.
Neuroendocrinology.    impact factor:   3.214
2001;  73(3): 203-14

161:  Garrido MM, Martin S, Ambrosio E, Fuentes JA, Manzanares J.
Role of corticotropin-releasing hormone in gastrin-releasing peptide-mediated regulation of corticotropin and corticosterone secretion in male rats.
Neuroendocrinology.    impact factor:   3.214
1998;  68(2): 116-22

162:  Xiao YF, Ke Q, Wang SY, Yang Y, Wang GK, Morgan JP, Leaf A.
Point mutations in alpha-subunit of human cardiac Na+ channels alter Na+ current kinetics.
Biochem Biophys Res Commun.    impact factor:   3.161
2001;  281(1): 45-52

163:  He H, Chen AC, Davey RB, Ivie GW, George JE.
Identification of a point mutation in the para-type sodium channel gene from a pyrethroid-resistant cattle tick.
Biochem Biophys Res Commun.    impact factor:   3.161
1999;  261(3): 558-61

164:  Billi AM, Matteucci A, Faenza I, Manzoli L, Rubbini S, Gilmour RS, Rhee SG, Cocco L.
Control of expression of PLCbeta1 by LAC repressor system: relationship between nuclear PLCbeta1 overexpression and growth factor stimulation.
Biochem Biophys Res Commun.    impact factor:   3.161
1997;  241(1): 122-6

165:  Schally AV, Comaru-Schally AM, Plonowski A, Nagy A, Halmos G, Rekasi Z.
Peptide analogs in the therapy of prostate cancer.
Prostate.    impact factor:   3.037
2000;  45(2): 158-66

166:  Sun B, Halmos G, Schally AV, Wang X, Martinez M.
Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers.
Prostate.    impact factor:   3.037
2000;  42(4): 295-303

167:  Plonowski A, Schally AV, Varga JL, Rekasi Z, Hebert F, Halmos G, Groot K.
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways.
Prostate.    impact factor:   3.037
2000;  44(2): 172-80

168:  Jungwirth A, Galvan G, Pinski J, Halmos G, Szepeshazi K, Cai RZ, Groot K, Schally AV.
Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice.
Prostate.    impact factor:   3.037
1997;  32(3): 164-72

169:  Han K, Viallet J, Chevalier S, Zheng W, Bazinet M, Aprikian AG.
Characterization of intracellular calcium mobilization by bombesin-related neuropeptides in PC-3 human prostate cancer cells.
Prostate.    impact factor:   3.037
1997;  31(1): 53-60

170:  Yaney GC, Fairbanks JM, Deeney JT, Korchak HM, Tornheim K, Corkey BE.
Potentiation of insulin secretion by phorbol esters is mediated by PKC-alpha and nPKC isoforms.
Am J Physiol Endocrinol Metab.    impact factor:   2.98
2002;  283(5): E880-8

171:  Hansen L, Hartmann B, Bisgaard T, Mineo H, Jorgensen PN, Holst JJ.
Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum.
Am J Physiol Endocrinol Metab.    impact factor:   2.98
2000;  278(6): E1010-8

172:  Merali Z, Kent P, Anisman H.
Role of bombesin-related peptides in the mediation or integration of the stress response.
Cell Mol Life Sci.    impact factor:   2.891
2002;  59(2): 272-87

173:  Leopoldt D, Yee HF Jr, Rozengurt E.
Calyculin-A induces focal adhesion assembly and tyrosine phosphorylation of p125(Fak), p130(Cas), and paxillin in Swiss 3T3 cells.
J Cell Physiol.    impact factor:   2.827
2001;  188(1): 106-19

174:  Ryder NM, Guha S, Hines OJ, Reber HA, Rozengurt E.
G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation.
J Cell Physiol.    impact factor:   2.827
2001;  186(1): 53-64

175:  Leopoldt D, Yee HF Jr, Saab S, Rozengurt E.
Tyrosine phosphorylation of p125(Fak), p130(Cas), and paxillin does not require extracellular signal-regulated kinase activation in Swiss 3T3 cells stimulated by bombesin or platelet-derived growth factor.
J Cell Physiol.    impact factor:   2.827
2000;  183(2): 208-20

176:  Rozengurt E.
Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists.
J Cell Physiol.    impact factor:   2.827
1998;  177(4): 507-17

177:  Carvalho RS, Schaffer JL, Gerstenfeld LC.
Osteoblasts induce osteopontin expression in response to attachment on fibronectin: demonstration of a common role for integrin receptors in the signal transduction processes of cell attachment and mechanical stimulation.
J Cell Biochem.    impact factor:   2.817
1998;  70(3): 376-90

178:  Fukatsu K, Lundberg AH, Kudsk KA, Hanna MK, Johnson CD, Wu Y, Wilcox HG, Zarzaur BL.
Modulation of organ ICAM-1 expression during IV-TPN with glutamine and bombesin.
Shock.    impact factor:   2.808
2001;  15(1): 24-8

179:  Chatelain D, Chailley-Heu B, Terris B, Molas G, Le Cae A, Vilgrain V, Belghiti J, Degott C, Flejou JF.
The ciliated hepatic foregut cyst, an unusual bronchiolar foregut malformation: a histological, histochemical, and immunohistochemical study of 7 cases.
Hum Pathol.    impact factor:   2.749
2000;  31(2): 241-6

180:  Heppenstall PA, Fleetwood-Walker SM.
Glycine receptor regulation of neurokinin1 receptor function in rat dorsal horn neurones.
Neuroreport.    impact factor:   2.682
1997;  8(14): 3109-12

181:  Ijsselstijn H, Gaillard JL, de Jongste JC, Tibboel D, Cutz E.
Abnormal expression of pulmonary bombesin-like peptide immunostaining cells in infants with congenital diaphragmatic hernia.
Pediatr Res.    impact factor:   2.671
1997;  42(5): 715-20

182:  Kiehne K, Herzig KH, Otte JM, Folsch UR.
Low-affinity CCK-1 receptors inhibit bombesin-stimulated secretion in rat pancreatic acini--implication of the actin cytoskeleton.
Regul Pept.    impact factor:   2.634
2002;  105(2): 131-7

183:  Moro F, Levenez F, Durual S, Plaisancie P, Thim L, Giraud AS, Cuber J.
Secretion of the trefoil factor TFF3 from the isolated vascularly perfused rat colon.
Regul Pept.    impact factor:   2.634
2001;  101(1-3): 35-41

184:  Tzschentke B, Basta D, Gourine AV, Gourine VN.
Influence of bombesin on neuronal hypothalamic thermosensitivity during the early postnatal period in the Muscovy duck (Cairina moschata).
Regul Pept.    impact factor:   2.634
2000;  88(1-3): 33-9

185:  Sun B, Schally AV, Halmos G.
The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers.
Regul Pept.    impact factor:   2.634
2000;  90(1-3): 77-84

186:  Ladenheim EE, Wohn A, White WO, Schwartz GJ, Moran TH.
Inhibition of gastric emptying by bombesin-like peptides is dependent upon cholecystokinin-A receptor activation.
Regul Pept.    impact factor:   2.634
1999;  84(1-3): 101-6

187:  Lhoste EF, Levenez F, Chabanet C, Fiszlewicz M, Corring T.
Effect of bombesin at low doses on the secretion of the exocrine pancreas and on plasma gastrin concentration in the conscious pig.
Regul Pept.    impact factor:   2.634
1998;  74(1): 41-5

188:  Weigert N, Li YY, Schick RR, Coy DH, Classen M, Schusdziarra V.
Role of vagal fibers and bombesin/gastrin-releasing peptide-neurons in distention-induced gastrin release in rats.
Regul Pept.    impact factor:   2.634
1997;  69(1): 33-40

189:  Rowland NE, Crews EC, Gentry RM.
Comparison of Fos induced in rat brain by GLP-1 and amylin.
Regul Pept.    impact factor:   2.634
1997;  71(3): 171-4

190:  Gibson GE, Zhang H, Xu H, Park LC, Jeitner TM.
Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme.
Biochim Biophys Acta.    impact factor:   2.59
2002;  1586(2): 177-89

191:  Garcia LJ, Pradhan TK, Weber HC, Moody TW, Jensen RT.
The gastrin-releasing peptide receptor is differentially coupled to adenylate cyclase and phospholipase C in different tissues.
Biochim Biophys Acta.    impact factor:   2.59
1997;  1356(3): 343-54

192:  Cross MJ, Hodgkin MN, Plumb JA, Brunton VG, Stewart A, MacAully G, Hill R, Kerr DJ, Workman P, Wakelam MJ.
Inhibition of phospholipid signalling and proliferation of Swiss 3T3 cells by the wortmannin analogue demethoxyviridin.
Biochim Biophys Acta.    impact factor:   2.59
1997;  1362(1): 29-38

193:  Ladenheim EE, Hampton LL, Whitney AC, White WO, Battey JF, Moran TH.
Disruptions in feeding and body weight control in gastrin-releasing peptide receptor deficient mice.
J Endocrinol.    impact factor:   2.58
2002;  174(2): 273-81

194:  Saifia S, Chevrier AM, Bosshard A, Cuber JC, Chayvialle JA, Abello J.
Galanin inhibits glucagon-like peptide-1 secretion through pertussis toxin-sensitive G protein and ATP-dependent potassium channels in rat ileal L-cells.
J Endocrinol.    impact factor:   2.58
1998;  157(1): 33-41

195:  Whitley JC, Shulkes A, Salamonsen LA, Vogiagis D, Familari M, Giraud AS.
Temporal expression and cellular localization of a gastrin-releasing peptide-related gene in ovine uterus during the oestrous cycle and pregnancy.
J Endocrinol.    impact factor:   2.58
1998;  157(1): 139-48

196:  Kaouass M, Deloyer P, Dandrifosse G.
Involvement of bombesin in spermine-induced corticosterone secretion and intestinal maturation in suckling rats.
J Endocrinol.    impact factor:   2.58
1997;  153(3): 429-36

197:  Yamada K, Wada E, Wada K.
Bombesin-like peptides: studies on food intake and social behaviour with receptor knock-out mice.
Ann Med.    impact factor:   2.566
2000;  32(8): 519-29

198:  Mann PT, Southwell BR, Young HM, Furness JB.
Appositions made by axons of descending interneurons in the guinea-pig small intestine, investigated by confocal microscopy.
J Chem Neuroanat.    impact factor:   2.552
1997;  12(3): 151-64

199:  La Bella R, Garcia-Garayoa E, Bahler M, Blauenstein P, Schibli R, Conrath P, Tourwe D, Schubiger PA.
A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent.
Bioconjug Chem.    impact factor:   2.55
2002;  13(3): 599-604

200:  Karra SR, Schibli R, Gali H, Katti KV, Hoffman TJ, Higginbotham C, Sieckman GL, Volkert WA.
99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent.
Bioconjug Chem.    impact factor:   2.55
1999;  10(2): 254-60

201:  Baidoo KE, Lin KS, Zhan Y, Finley P, Scheffel U, Wagner HN Jr.
Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues.
Bioconjug Chem.    impact factor:   2.55
1998;  9(2): 218-25

202:  Miyazaki M, Lamharzi N, Schally AV, Halmos G, Szepeshazi K, Groot K, Cai RZ.
Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095.
Eur J Cancer.    impact factor:   2.537
1998;  34(5): 710-7

203:  Limonta P, Pratesi G, Moretti RM, Montagnani Marelli M, Motta M, Dondi D.
Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J Cancer 1997, 33(7), 1141-1148.
Eur J Cancer.    impact factor:   2.537
1998;  34(7): 1134-6

204:  Jungwirth A, Pinski J, Galvan G, Halmos G, Szepeshazi K, Cai RZ, Groot K, Vadillo-Buenfil M, Schally AV.
Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.
Eur J Cancer.    impact factor:   2.537
1997;  33(7): 1141-8

205:  Abdel-Gawad M, Dion SB, Elhilali MM.
Evidence of a peripheral role of neurokinins in detrusor hyperreflexia: a further study of selective tachykinin antagonists in chronic spinal injured rats.
J Urol.    impact factor:   2.486
2001;  165(5): 1739-44

206:  Streefland L, Auffret AD, Franks F.
Bond cleavage reactions in solid aqueous carbohydrate solutions.
Pharm Res.    impact factor:   2.475
1998;  15(6): 843-9

207:  Kim JB, Johansson A, Holmgren S, Conlon JM.
Gastrin-releasing peptides from Xenopus laevis: purification, characterization, and myotropic activity.
Am J Physiol Regul Integr Comp Physiol.    impact factor:   2.453
2001;  281(3): R902-8

208:  Schoborg RV, Hoover DB, Tompkins JD, Hancock JC.
Increased ganglionic responses to substance P in hypertensive rats due to upregulation of NK(1) receptors.
Am J Physiol Regul Integr Comp Physiol.    impact factor:   2.453
2000;  279(5): R1685-94

209:  Dasgupta A, Biddle DA, Wells A, Datta P.
Positive and negative interference of the Chinese medicine Chan Su in serum digoxin measurement. Elimination of interference by using a monoclonal chemiluminescent digoxin assay or monitoring free digoxin concentration.
Am J Clin Pathol.    impact factor:   2.425
2000;  114(2): 174-9

210:  Schally AV, Nagy A.
Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.
Eur J Endocrinol.    impact factor:   2.421
1999;  141(1): 1-14

211:  Kelley MJ, Linnoila RI, Avis IL, Georgiadis MS, Cuttitta F, Mulshine JL, Johnson BE.
Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer.
Chest.    impact factor:   2.41
1997;  112(1): 256-61

212:  Alshehri M, Cutz E, Banzhoff A, Canny G.
Hyperplasia of pulmonary neuroendocrine cells in a case of childhood pulmonary emphysema.
Chest.    impact factor:   2.41
1997;  112(2): 553-6

213:  Mukherjee JJ, Huang JS, Getman C, Kiss Z.
Bombesin promotes synergistic stimulation of DNA synthesis by ethanol and insulin in fibroblasts.
Arch Biochem Biophys.    impact factor:   2.386
1999;  362(1): 183-9

214:  Huang JS, Mukherjee JJ, Kiss Z.
Ethanol potentiates the mitogenic effects of sphingosine 1-phosphate by a zinc- and calcium-dependent mechanism in fibroblasts.
Arch Biochem Biophys.    impact factor:   2.386
1999;  366(1): 131-8

215:  Zarzaur BL, Wu Y, Fukatsu K, Johnson CD, Kudsk KA.
The neuropeptide bombesin improves IgA-mediated mucosal immunity with preservation of gut interleukin-4 in total parenteral nutrition-fed mice.
Surgery.    impact factor:   2.344
2002;  131(1): 59-65

216:  Castaneda AA, Kim YS, Chang LK, Cui Y, Mercer DW.
Nitric oxide synthase inhibition negates bombesin-induced gastroprotection.
Surgery.    impact factor:   2.344
2000;  128(3): 422-8

217:  Mercer DW, Cross JM, Castaneda AA, Gunter JA.
Gastroprotective actions of bombesin, L-DOPA, and mild irritants: roles of prostaglandins and sensory neurons.
Surgery.    impact factor:   2.344
1998;  124(5): 864-70

218:  Williams CA, Reifsteck A, Hampton TA, Fry B.
Substance P release in the feline nucleus tractus solitarius during ergoreceptor but not baroreceptor afferent signaling.
Brain Res.    impact factor:   2.302
2002;  944(1-2): 19-31

219:  Merali Z, Kent P, Michaud D, McIntyre D, Anisman H.
Differential impact of predator or immobilization stressors on central corticotropin-releasing hormone and bombesin-like peptides in Fast and Slow seizing rat.
Brain Res.    impact factor:   2.302
2001;  906(1-2): 60-73

220:  Ishikawa T, Yang H, Tache Y.
Microinjection of bombesin into the ventrolateral reticular formation inhibits peripherally stimulated gastric acid secretion through spinal pathways in rats.
Brain Res.    impact factor:   2.302
2001;  918(1-2): 1-9

221:  Gotoh M, Takagi J, Mori S, Yatoh M, Hirooka Y, Yamanouchi K, Smythe GA.
Octreotide-induced suppression of the hyperglycemic response to neostigmine or bombesin: relationship to hypothalamic noradrenergic drive.
Brain Res.    impact factor:   2.302
2001;  919(1): 155-9

222:  Chao HM, Chidlow G, Melena J, Wood JP, Osborne NN.
An investigation into the potential mechanisms underlying the neuroprotective effect of clonidine in the retina.
Brain Res.    impact factor:   2.302
2000;  877(1): 47-57

223:  Shimojo M, Takasugi K, Yamamoto I, Funato H, Mochizuki H, Kohsaka S.
Neuroprotective action of a novel compound--M50463--in primary cultured neurons.
Brain Res.    impact factor:   2.302
1999;  815(1): 131-9

224:  Garrido MM, Manzanares J, Fuentes JA.
Hypothalamus, anterior pituitary and adrenal gland involvement in the activation of adrenocorticotropin and corticosterone secretion by gastrin-releasing peptide.
Brain Res.    impact factor:   2.302
1999;  828(1-2): 20-6

225:  Johnson MD, Ko M, Choo KS, Traynor JR, Mosberg HI, Naughton NN, Woods JH.
The effects of the phyllolitorin analogue [desTrp(3), Leu(8)]phyllolitorin on scratching induced by bombesin and related peptides in rats.
Brain Res.    impact factor:   2.302
1999;  839(1): 194-8

226:  Vigh J, Lenard L, Fekete E.
Bombesin microinjection into the basolateral amygdala influences feeding behavior in the rat.
Brain Res.    impact factor:   2.302
1999;  847(2): 253-61

227:  Rashidy-Pour A, Razvani ME.
Unilateral reversible inactivations of the nucleus tractus solitarius and amygdala attenuate the effects of bombesin on memory storage.
Brain Res.    impact factor:   2.302
1998;  814(1-2): 127-32

228:  Plamondon H, Lambert C, Merali Z.
Sustained bombesin exposure results in receptor down-regulation and tolerance to the chronic but not acute effects of bombesin on ingestion.
Brain Res.    impact factor:   2.302
1998;  782(1-2): 202-11

229:  Reynolds T, Pinnock RD.
Neuromedin C decreases potassium conductance and increases a non-specific conductance in rat suprachiasmatic neurones in brain slices in vitro.
Brain Res.    impact factor:   2.302
1997;  750(1-2): 67-80

230:  Ramirez MJ, Cenarruzabeitia E, Lasheras B, Del Rio J.
5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Brain Res.    impact factor:   2.302
1997;  757(1): 17-23

231:  Cristoni S, Bernardi LR, Biunno I, Guidugli F.
Analysis of peptides using partial (no discharge) atmospheric pressure chemical ionization conditions with ion trap mass spectrometry.
Rapid Commun Mass Spectrom.    impact factor:   2.184
2002;  16(17): 1686-91

232:  Vishwanathan K, Bartlett MG, Stewart JT.
Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometry.
Rapid Commun Mass Spectrom.    impact factor:   2.184
2000;  14(3): 168-72

233:  Lai R, Liu H, Lee WH, Zhang Y.
A novel proline rich bombesin-related peptide (PR-bombesin) from toad Bombina maxima.
Peptides.    impact factor:   2.173
2002;  23(3): 437-42

234:  Kent P, Bedard T, Khan S, Anisman H, Merali Z.
Bombesin-induced HPA and sympathetic activation requires CRH receptors.
Peptides.    impact factor:   2.173
2001;  22(1): 57-65

235:  Burghardt B, Wenger C, Barabas K, Racz G, Olah A, Flautner L, Coy DH, Gress TM, Varga G.
GRP-receptor-mediated signal transduction, gene expression and DNA synthesis in the human pancreatic adenocarcinoma cell line HPAF.
Peptides.    impact factor:   2.173
2001;  22(7): 1119-28

236:  Casibang M, Moody TW.
(Tyr(0),Bpa(4))bombesin is a GRP receptor agonist.
Peptides.    impact factor:   2.173
2000;  21(5): 649-53

237:  Volkoff H, Peyon P, Lin X, Peter RE.
Molecular cloning and expression of cDNA encoding a brain bombesin/gastrin-releasing peptide-like peptide in goldfish.
Peptides.    impact factor:   2.173
2000;  21(5): 639-48

238:  Emanuel RL, Torday JS, Asokananthan N, Sunday ME.
Direct effects of corticotropin-releasing hormone and thyrotropin-releasing hormone on fetal lung explants.
Peptides.    impact factor:   2.173
2000;  21(12): 1819-29

239:  Cullen A, Emanuel RL, Torday JS, Asokananthan N, Sikorski KA, Sunday ME.
Bombesin-like peptide and receptors in lung injury models: diverse gene expression, similar function.
Peptides.    impact factor:   2.173
2000;  21(11): 1627-38

240:  Martinez V, Tache Y.
Bombesin and the brain-gut axis.
Peptides.    impact factor:   2.173
2000;  21(11): 1617-25

241:  Alican I, Unluer EE, Yegen C, Yegen BC.
Bombesin improves burn-induced intestinal injury in the rat.
Peptides.    impact factor:   2.173
2000;  21(8): 1265-9

242:  Vigh J, Lenard L, Fekete E, Hernadi I.
Bombesin injection into the central amygdala influences feeding behavior in the rat.
Peptides.    impact factor:   2.173
1999;  20(4): 437-44

243:  Stiffler DF.
Electrophysiological responses of frog skin to the peptides bombesin, caerulein, and physalaemin.
Peptides.    impact factor:   2.173
1999;  20(10): 1239-41

244:  Alvaro-Alonso I, Munoz-Acedo G, Rodriguez-Martin E, Schally AV, Arilla E.
Bombesin induces a reduction of somatostatin inhibition of adenylyl cyclase activity, Gi function, and somatostatin receptors in rat exocrine pancreas.
Peptides.    impact factor:   2.173
1999;  20(6): 723-30

245:  D'Este L, Falconieri-Erspamer G, Severini C, Erspamer V, Renda TG.
Neuropeptide Y release by pumiliotoxin-B in the electrically-stimulated mouse vas deferens: an immunohistochemical study.
Peptides.    impact factor:   2.173
1999;  20(7): 809-16

246:  Koh SW, Leyton J, Moody TW.
Bombesin activates MAP kinase in non-small cell lung cancer cells.
Peptides.    impact factor:   2.173
1999;  20(1): 121-6

247:  Carroll RE, Carroll R, Benya RV.
Characterization of gastrin-releasing peptide receptors aberrantly expressed by non-antral gastric adenocarcinomas.
Peptides.    impact factor:   2.173
1999;  20(2): 229-37

248:  Azay J, Nagain C, Llinares M, Devin C, Fehrentz JA, Bernad N, Roze C, Martinez J.
Comparative study of in vitro and in vivo activities of bombesin pseudopeptide analogs modified on the C-terminal dipeptide fragment.
Peptides.    impact factor:   2.173
1998;  19(1): 57-63

249:  Covasa M, Ritter RC.
Rats maintained on high-fat diets exhibit reduced satiety in response to CCK and bombesin.
Peptides.    impact factor:   2.173
1998;  19(8): 1407-15

250:  Aalto Y, Forsgren S, Kjorell U, Bergh J, Franzen L, Henriksson R.
Enhanced expression of neuropeptides in human breast cancer cell lines following irradiation.
Peptides.    impact factor:   2.173
1998;  19(2): 231-9

251:  Milusheva EA, Kortezova NI, Mizhorkova ZN, Papasova M, Coy DH, Balint A, Vizi ES, Varga G.
Role of different bombesin receptor subtypes mediating contractile activity in cat upper gastrointestinal tract.
Peptides.    impact factor:   2.173
1998;  19(3): 549-56

252:  de Caro G, Polidori C, Beltz TG, Johnson AK.
Area postrema, lateral parabrachial nucleus, and the antinatriorexic effect of bombesin.
Peptides.    impact factor:   2.173
1998;  19(8): 1399-406

253:  Carbone A, Schloithe AC, Harvey JR, Baker RA, Saccone GT.
Gastrin-releasing peptide stimulates possum gallbladder contractility in vitro.
Peptides.    impact factor:   2.173
1997;  18(7): 1067-71

254:  Au CL, Canny BJ, Farnworth PG, Giraud AS.
Bombesin regulation of adrenocorticotropin release from ovine anterior pituitary cells.
Peptides.    impact factor:   2.173
1997;  18(7): 995-1000

255:  Smith J, Perez S, Rushing PA, Smith GP, Gibbs J.
Gastrin-releasing peptide1-27, unlike bombesin, does not reduce sham feeding in rats.
Peptides.    impact factor:   2.173
1997;  18(9): 1465-7

256:  Sharif TR, Luo W, Sharif M.
Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway.
Mol Cell Endocrinol.    impact factor:   2.136
1997;  130(1-2): 119-30

257:  Pastor N, Dominguez I, Mateos S, Cortes F.
A comparative study of genotoxic effects of anti-topoisomerase II drugs ICRF-193 and bufalin in Chinese hamster ovary cells.
Mutat Res.    impact factor:   2.107
2002;  515(1-2): 171-80

258:  Westermark T, Isaksson T, Holmberg P, Kjorell U, Rantapaa-Dahlqvist S, Forsgren S.
Increase in bombesin-like peptides in the spinal cord after dexamethasone treatment of adrenalectomized rats.
Neurosci Lett.    impact factor:   2.085
1999;  275(3): 179-82

259:  Frenkel C, Weckbecker K, Wartenberg HC, Duch DS, Urban BW.
Blocking effects of the anaesthetic etomidate on human brain sodium channels.
Neurosci Lett.    impact factor:   2.085
1998;  249(2-3): 131-4

260:  Frenkel C, Gerhard A, Wartenberg HC, Rehberg B, Urban BW.
No evidence for specific opioid effects on batrachotoxin-modified sodium channels from human brain synaptosomes.
Neurosci Lett.    impact factor:   2.085
1997;  229(1): 41-4

261:  Novotna R, Novotny I.
Stimulatory effect of bombesin on phosphoinositide metabolism in the rat pineal gland.
Neurosci Lett.    impact factor:   2.085
1997;  234(2-3): 119-22

262:  Mason S, Smart D, Marshall IC, McKnight A, Skepper JN, McNulty S.
Identification and characterisation of functional bombesin receptors in human astrocytes.
Eur J Pharmacol.    impact factor:   2.047
2002;  438(1-2): 25-34

263:  Yamada K, Wada E, Santo-Yamada Y, Wada K.
Bombesin and its family of peptides: prospects for the treatment of obesity.
Eur J Pharmacol.    impact factor:   2.047
2002;  440(2-3): 281-90

264:  Weber HC, Walters J, Leyton J, Casibang M, Purdom S, Jensen RT, Coy DH, Ellis C, Clark G, Moody TW.
A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells.
Eur J Pharmacol.    impact factor:   2.047
2001;  412(1): 13-20

265:  Oiry C, Pannequin J, Bernad N, Artis AM, Galleyrand JC, Devin C, Cristau M, Fehrentz JA, Martinez J.
A synthetic glycine-extended bombesin analogue interacts with the GRP/bombesin receptor.
Eur J Pharmacol.    impact factor:   2.047
2000;  403(1-2): 17-25

266:  Melena J, Chidlow G, Osborne NN.
Blockade of voltage-sensitive Na(+) channels by the 5-HT(1A) receptor agonist 8-OH-DPAT: possible significance for neuroprotection.
Eur J Pharmacol.    impact factor:   2.047
2000;  406(3): 319-24

267:  Bartho L, Lazar Z, Lenard L, Benko R, Toth G, Penke B, Szolcsanyi J, Maggi CA.
Evidence for the involvement of ATP, but not of VIP/PACAP or nitric oxide, in the excitatory effect of capsaicin in the small intestine.
Eur J Pharmacol.    impact factor:   2.047
2000;  392(3): 183-8

268:  Brough SJ, Jerman JC, Jewitt F, Smart D.
Characterisation of an endogenous bombesin receptor in CHO/DG44 cells.
Eur J Pharmacol.    impact factor:   2.047
2000;  409(3): 259-63

269:  Kamei J, Ohsawa M, Suzuki T, Saitoh A, Endoh T, Narita M, Tseng LF, Nagase H.
The modulatory effect of (+)-TAN-67 on the antinociceptive effects of the nociceptin/orphanin FQ in mice.
Eur J Pharmacol.    impact factor:   2.047
1999;  383(3): 241-7

270:  Rudd JA, Ngan MP, Wai MK.
Inhibition of emesis by tachykinin NK1 receptor antagonists in Suncus murinus (house musk shrew).
Eur J Pharmacol.    impact factor:   2.047
1999;  366(2-3): 243-52

271:  Sakurada T, Yuhki M, Inoue M, Sakurada C, Tan-No K, Ohba M, Kisara K, Sakurada S.
Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
Eur J Pharmacol.    impact factor:   2.047
1999;  369(3): 261-6

272:  Pradhan TK, Katsuno T, Taylor JE, Kim SH, Ryan RR, Mantey SA, Donohue PJ, Weber HC, Sainz E, Battey JF, Coy DH, Jensen RT.
Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
Eur J Pharmacol.    impact factor:   2.047
1998;  343(2-3): 275-87

273:  Damge C, Hajri A.
Effect of the gastrin-releasing peptide antagonist BIM 26226 and lanreotide on an acinar pancreatic carcinoma.
Eur J Pharmacol.    impact factor:   2.047
1998;  347(1): 77-86

274:  Plamondon H, Merali Z.
Anorectic action of bombesin requires receptor for corticotropin-releasing factor but not for oxytocin.
Eur J Pharmacol.    impact factor:   2.047
1997;  340(2-3): 99-109

275:  Slice LW, Yee HF Jr, Walsh JH.
Visualization of internalization and recycling of the gastrin releasing peptide receptor-green fluorescent protein chimera expressed in epithelial cells.
Receptors Channels.    impact factor:   2.019
1998;  6(3): 201-12

276:  Konety BR, Nelson JB.
Nonandrogenic mediators of prostatic growth.
Hematol Oncol Clin North Am.    impact factor:   1.979
2001;  15(3): 459-76

277:  Allard P, Beaulieu P, Aprikian A, Chevalier S.
Bombesin modulates the association of Src with a nuclear 110-kd protein expressed in dividing prostate cells.
J Androl.    impact factor:   1.972
2000;  21(3): 367-75

278:  Poornima S, Christian C, Kresch MJ.
Developmental regulation of SP-A receptor in fetal rat lung.
Lung.    impact factor:   1.925
2002;  180(1): 33-46

279:  Kresch M, Christian C, Zhu L, Obe M, Sanders MM, Hussain N.
Bombesin inhibits apoptosis in developing fetal rat lung.
Lung.    impact factor:   1.925
1999;  177(4): 241-51

280:  Pansky A, Hildebrand P, Heim MH, Eberhard M, Kissel T, Beglinger C.
Growth effects of alpha-interferon but not of bombesin or angiotensin II are mediated by activation of STAT proteins.
Eur J Clin Invest.    impact factor:   1.922
1998;  28(5): 398-406

281:  Tatsuta A, Iishi H, Baba M, Yano H, Murata K, Mukai M, Akedo H.
Suppression by apigenin of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats.
Clin Exp Metastasis.    impact factor:   1.845
2000;  18(8): 657-62

282:  Iishi H, Tatsuta M, Baba M, Uehara H, Nakaizumi A, Shinkai K, Akedo H, Funai H, Ishiguro S, Kitagawa I.
Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats.
Clin Exp Metastasis.    impact factor:   1.845
1997;  15(6): 603-11

283:  Ohlsson B, Fredang N, Axelson J.
The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines.
Scand J Gastroenterol.    impact factor:   1.842
1999;  34(12): 1224-9

284:  Fiorucci S, Bufalari A, Distrutti E, Bufalari A, Lanfrancone L, Servoli A, Sarpi L, Federici B, Bartoli A, Morelli A, Moggi L.
Bombesin-induced pancreatic regeneration in pigs is mediated by p46Shc/p52Shc and p42/p44 mitogen-activated protein kinase upregulation.
Scand J Gastroenterol.    impact factor:   1.842
1998;  33(12): 1310-20

285:  Sandvik AK, Brenna E, Sundan A, Holst JJ, Waldum HI.
Bombesin inhibits histamine release from the rat oxyntic mucosa by a somatostatin-dependent mechanism.
Scand J Gastroenterol.    impact factor:   1.842
1997;  32(5): 427-32

286:  Garrido MM, Fuentes JA, Manzanares J.
Gastrin-releasing peptide mediated regulation of 5-HT neuronal activity in the hypothalamic paraventricular nucleus under basal and restraint stress conditions.
Life Sci.    impact factor:   1.774
2002;  70(25): 2953-66

287:  Oda M, Kurosawa M, Numazawa S, Tanaka S, Akizawa T, Ito K, Maeda M, Yoshida T.
Determination of bufalin-like immunoreactivity in serum of humans and rats by time-resolved fluoroimmunoassay for using a monoclonal antibody.
Life Sci.    impact factor:   1.774
2001;  68(10): 1107-17

288:  Kent P, Anisman H, Merali Z.
Are bombesin-like peptides involved in the mediation of stress response?
Life Sci.    impact factor:   1.774
1998;  62(2): 103-14

289:  Okuma Y, Yokotani K, Murakami Y, Osumi Y.
Brain histamine mediates the bombesin-induced central activation of sympatho-adrenomedullary outflow.
Life Sci.    impact factor:   1.774
1997;  61(26): 2521-8

290:  Wright SN.
Comparison of aconitine-modified human heart (hH1) and rat skeletal (mu1) muscle Na+ channels: an important role for external Na+ ions.
J Physiol.    impact factor:   1.773
2002;  538(Pt 3): 759-71

291:  Szalmay G, Varga G, Kajiyama F, Yang XS, Lang TF, Case RM, Steward MC.
Bicarbonate and fluid secretion evoked by cholecystokinin, bombesin and acetylcholine in isolated guinea-pig pancreatic ducts.
J Physiol.    impact factor:   1.773
2001;  535(Pt 3): 795-807

292:  Yasuda K, Robinson DM, Selvaratnam SR, Walsh CW, McMorland AJ, Funk GD.
Modulation of hypoglossal motoneuron excitability by NK1 receptor activation in neonatal mice in vitro.
J Physiol.    impact factor:   1.773
2001;  534(Pt. 2): 447-64

293:  Lee K, Dixon AK, Gonzalez I, Stevens EB, McNulty S, Oles R, Richardson PJ, Pinnock RD, Singh L.
Bombesin-like peptides depolarize rat hippocampal interneurones through interaction with subtype 2 bombesin receptors.
J Physiol.    impact factor:   1.773
1999;  518 ( Pt 3): 791-802

294:  Rushing PA.
Spontaneous and scheduled eating: microstructural and peptide effects.
Appetite.    impact factor:   1.76
1997;  29(3): 385

295:  Flowers A, Onwueme K, Creveling CR, Daly JW.
Reserpine: interactions with batrachotoxin and brevetoxin sites on voltage-dependent sodium channels.
Cell Mol Neurobiol.    impact factor:   1.752
2002;  22(1): 1-12

296:  Stahlman MT, Gray ME.
Immunogold EM localization of neurochemicals in human pulmonary neuroendocrine cells.
Microsc Res Tech.    impact factor:   1.746
1997;  37(1): 77-91

297:  Diaz-Romero M, Eguibar JR, Moyaho A.
Bombesin decreases yawning in a high-yawning subline of Sprague-Dawley rats.
Pharmacol Biochem Behav.    impact factor:   1.732
2002;  71(1-2): 103-9

298:  Fitch RW, Luzzio FA.
Ultrasound in natural products synthesis: applications to the synthesis of histrionicotoxin via nitroalkanal acetals.
Ultrason Sonochem.    impact factor:   1.732
1997;  4(2): 99-107

299:  Takiguchi S, Suzuki S, Sato Y, Kanai S, Miyasaka K, Jimi A, Shinozaki H, Takata Y, Funakoshi A, Kono A, Minowa O, Kobayashi T, Noda T.
Role of CCK-A receptor for pancreatic function in mice: a study in CCK-A receptor knockout mice.
Pancreas.    impact factor:   1.685
2002;  24(3): 276-83

300:  Miyasaka K, Shinozaki H, Jimi A, Funakoshi A.
Amylase secretion from dispersed human pancreatic acini: neither cholecystokinin a nor cholecystokinin B receptors mediate amylase secretion in vitro.
Pancreas.    impact factor:   1.685
2002;  25(2): 161-5

301:  Murphy LO, Abdel-Wahab YH, Wang QJ, Knezetic JA, Permnert J, Larsson J, Hollingsworth AM, Adrian TE.
Receptors and ligands for autocrine growth pathways are up-regulated when pancreatic cancer cells are adapted to serum-free culture.
Pancreas.    impact factor:   1.685
2001;  22(3): 293-8

302:  Takahashi A, Tanaka S, Miwa Y, Yoshida H, Ikegami A, Niikawa J, Mitamura K.
Involvement of calmodulin and protein kinase C in cholecystokinin release by bombesin from STC-1 cells.
Pancreas.    impact factor:   1.685
2000;  21(3): 231-9

303:  Eddes EH, Masclee AA, Gielkens HA, Verkijk M, Vecht J, Biemond I, Lamers CB.
Cholecystokinin secretion in patients with chronic pancreatitis and after different types of pancreatic surgery.
Pancreas.    impact factor:   1.685
1999;  19(2): 119-25

304:  Lam WF, Masclee AA, Muller ES, Souverijn JH, Lamers CB.
Effect of acute hyperglycemia on basal and bombesin-stimulated pancreaticobiliary secretion in humans.
Pancreas.    impact factor:   1.685
1998;  17(2): 201-7

305:  Lieverse RJ, Masclee AA, Jansen JB, Lam WF, Lamers CB.
Obese women are less sensitive for the satiety effects of bombesin than lean women.
Eur J Clin Nutr.    impact factor:   1.668
1998;  52(3): 207-12

306:  Smith BP, Tyler MJ, Kaneko T, Garraffo HM, Spande TF, Daly JW.
Evidence for biosynthesis of pseudophrynamine alkaloids by an Australian myobatrachid frog (pseudophryne) and for sequestration of dietary pumiliotoxins.
J Nat Prod.    impact factor:   1.652
2002;  65(4): 439-47

307:  Mokotoff M, Mocarski YM, Gentsch BL, Miller MR, Zhou JH, Chen J, Ball ED.
Caution in the use of 2-iminothiolane (Traut's reagent) as a cross-linking agent for peptides. The formation of N-peptidyl-2-iminothiolanes with bombesin (BN) antagonist (D-Trp(6),Leu(13)-psi[CH(2)NH]-Phe(14))BN(6-14) and D-Trp-Gln-Trp-NH(2).
J Pept Res.    impact factor:   1.638
2001;  57(5): 383-9

308:  Condamine E, Chapdeleine G, Demarcy L, Duclos JF, Davoust D, Llinares M, Azay J, Martinez J, Chapelle S.
Biological activity and three-dimensional structure of an agonist analog of bombesin.
J Pept Res.    impact factor:   1.638
1998;  51(1): 55-64

309:  Gasmi G, Singer A, Forman-Kay J, Sarkar B.
NMR structure of neuromedin C, a neurotransmitter with an amino terminal CuII-, NiII-binding (ATCUN) motif.
J Pept Res.    impact factor:   1.638
1997;  49(6): 500-9

310:  Hu F, Cutler CS, Hoffman T, Sieckman G, Volkert WA, Jurisson SS.
Pm-149 DOTA bombesin analogs for potential radiotherapy. in vivo comparison with Sm-153 and Lu-177 labeled DO3A-amide-betaAla-BBN(7-14)NH(2).
Nucl Med Biol.    impact factor:   1.623
2002;  29(4): 423-30

311:  Salido M, Vilches J, Lopez A.
Neuropeptides bombesin and calcitonin induce resistance to etoposide induced apoptosis in prostate cancer cell lines.
Histol Histopathol.    impact factor:   1.601
2000;  15(3): 729-38

312:  Hochol A, Markowska A, Meneghelli V, Jedrzejczak N, Majchrzak M, Nowak M, Nussdorfer GG, Malendowicz LK.
Effects of neurotensin and bombesin on the secretory and proliferative activity of regenerating rat adrenal cortex.
Histol Histopathol.    impact factor:   1.601
1999;  14(4): 1073-8

313:  Arrighi S, Domeneghini C.
Immunolocalization of regulatory peptides and 5-HT in bovine male urogenital apparatus.
Histol Histopathol.    impact factor:   1.601
1998;  13(4): 1049-59

314:  Arrighi S, Domeneghini C.
Localization of regulatory peptides in the male urogenital apparatus of domestic equidae: a comparative immunohistochemical study in Equus caballus and Equus asinus.
Histol Histopathol.    impact factor:   1.601
1997;  12(2): 297-310

315:  Alcain FJ, Low H.
Ceruloplasmin releases pH-induced inhibition of cell proliferation stimulated by growth factors.
Redox Rep.    impact factor:   1.581
1997;  3(5-6): 287-93

316:  Keith Hanna M, Zarzaur BL Jr, Fukatsu K, Chance DeWitt R, Renegar KB, Sherrell C, Wu Y, Kudsk KA.
Individual neuropeptides regulate gut-associated lymphoid tissue integrity, intestinal immunoglobulin A levels, and respiratory antibacterial immunity.
JPEN J Parenter Enteral Nutr.    impact factor:   1.58
2000;  24(5): 261-8; discussion 268-9

317:  Yule KA, White SR.
Migration of 3T3 and lung fibroblasts in response to calcitonin gene-related peptide and bombesin.
Exp Lung Res.    impact factor:   1.563
1999;  25(3): 261-73

318:  Suzuki Y, Motoi H, Sato K.
Quantitative analysis of pyroglutamic acid in peptides.
J Agric Food Chem.    impact factor:   1.56
1999;  47(8): 3248-51

319:  Douziech N, Lajas A, Coulombe Z, Calvo E, Laine J, Morisset J.
Growth effects of regulatory peptides and intracellular signaling routes in human pancreatic cancer cell lines.
Endocrine.    impact factor:   1.533
1998;  9(2): 171-83

320:  Leyton J, Garcia-Marin LJ, Tapia JA, Jensen RT, Moody TW.
Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cells.
Cancer Lett.    impact factor:   1.518
2001;  162(1): 87-95

321:  Chatzistamou I, Schally AV, Szepeshazi K, Groot K, Hebert F, Arencibia JM.
Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix.
Cancer Lett.    impact factor:   1.518
2001;  171(1): 37-45

322:  Cassano G, Resta N, Gasparre G, Lippe C, Guanti G.
The proliferative response of HT-29 human colon adenocarcinoma cells to bombesin-like peptides.
Cancer Lett.    impact factor:   1.518
2001;  172(2): 151-7

323:  Cassano G, Gasparre G, Susca F, Lippe C, Guanti G.
Effect of prostaglandin E(2) on the proliferation, Ca(2+) mobilization and cAMP in HT-29 human colon adenocarcinoma cells.
Cancer Lett.    impact factor:   1.518
2000;  152(2): 217-22

324:  Heusch WL, Maneckjee R.
Effects of bombesin on methadone-induced apoptosis of human lung cancer cells.
Cancer Lett.    impact factor:   1.518
1999;  136(2): 177-85

325:  Nelson JB, Carducci MA.
Small bioactive peptides and cell surface peptidases in androgen-independent prostate cancer.
Cancer Invest.    impact factor:   1.514
2000;  18(1): 87-96

326:  Bold RJ, Kim HJ, Ishizuka J, Townsend CM Jr, Thompson JC.
A human gastric cancer cell line possesses a functional receptor for gastrin-releasing peptide.
Cancer Invest.    impact factor:   1.514
1998;  16(1): 12-7

327:  Yamada K, Hino K, Tomoyasu S, Honma Y, Tsuruoka N.
Enhancement by bufalin of retinoic acid-induced differentiation of acute promyelocytic leukemia cells in primary culture.
Leuk Res.    impact factor:   1.502
1998;  22(7): 589-95

328:  Beales IL.
Effect of platelet-activating factor on gastrin release from cultured rabbit G-cells.
Dig Dis Sci.    impact factor:   1.498
2001;  46(2): 301-6

329:  Gulluoglu BM, Kurtel H, Gulluoglu MG, Aktan AO, Yegen BC, Dizdaroglu F, Yalin R, Yegen BC.
Bombesin ameliorates colonic damage in experimental colitis.
Dig Dis Sci.    impact factor:   1.498
1999;  44(8): 1531-8

330:  Soldani G, Bertini S, Rouleau A, Schwartz JC, Coruzzi G.
Gastric antisecretory effects of compound BP 2-94: a histamine H3-receptor agonist prodrug.
Dig Dis Sci.    impact factor:   1.498
1999;  44(12): 2380-5

331:  Thimister PW, Hopman WP, Rosenbusch G, Jansen JB.
Plasma cholecystokinin and gallbladder responses to increasing doses of bombesin in celiac disease.
Dig Dis Sci.    impact factor:   1.498
1998;  43(3): 668-72

332:  Mercer DW, Cross JM, Chang L, Lichtenberger LM.
Bombesin prevents gastric injury in the rat: role of gastrin.
Dig Dis Sci.    impact factor:   1.498
1998;  43(4): 826-33

333:  Kim HJ, Evers BM, Banker NA, Greeley GH Jr, Hellmich MR, Thompson JC, Townsend CM Jr.
Novel expression and regulation of gastrin gene in human ovarian cancer cell line, SW626.
Dig Dis Sci.    impact factor:   1.498
1998;  43(7): 1465-73

334:  Huntington MK, Geary TG, Mackenzie CD, Williams JF.
Bombesin-like neuropeptides in nematodes.
J Parasitol.    impact factor:   1.485
1999;  85(3): 473-7

335:  Malendowicz LK.
Role of neuromedins in the regulation of adrenocortical function.
Horm Metab Res.    impact factor:   1.465
1998;  30(6-7): 374-83

336:  Heuser M, Pfaar O, Gralla O, Grone HJ, Nustede R, Post S.
Impact of gastrin-releasing peptide on intestinal microcirculation after ischemia-reperfusion in rats.
Digestion.    impact factor:   1.442
2000;  61(3): 172-80

337:  Weigert N, Schepp W, Haller A, Schusdziarra V.
Regulation of gastrin, somatostatin and bombesin release from the isolated rat stomach by exogenous and endogenous gamma-aminobutyric acid.
Digestion.    impact factor:   1.442
1998;  59(1): 16-25

338:  Friese J, Gleitz J.
Kavain, dihydrokavain, and dihydromethysticin non-competitively inhibit the specific binding of [3H]-batrachotoxinin-A 20-alpha-benzoate to receptor site 2 of voltage-gated Na+ channels.
Planta Med.    impact factor:   1.438
1998;  64(5): 458-9

339:  Eddes EH, Verkijk M, Gielkens HA, Biemond I, Bemelman W, Lamers CB, Masclee AA.
Pancreatic polypeptide secretion in patients with chronic pancreatitis and after pancreatic surgery.
Int J Pancreatol.    impact factor:   1.42
2001;  29(3): 173-80

340:  Aroni K, Charitopoulos KN, Lazaris AC, Davaris P.
Lack of vasopressin expression in malignant melanomas.
Melanoma Res.    impact factor:   1.414
2000;  10(6): 535

341:  Novak J, Escobedo-Morse A, Kelley K, Boose D, Kautzman-Eades D, Meyer M, Kane MA.
Nicotine effects on proliferation and the bombesin-like peptide autocrine system in human small cell lung carcinoma SHP77 cells in culture.
Lung Cancer.    impact factor:   1.401
2000;  29(1): 1-10

342:  Yang HK, Scott FM, Trepel JB, Battey JF, Johnson BE, Kelley MJ.
Correlation of expression of bombesin-like peptides and receptors with growth inhibition by an anti-bombesin antibody in small-cell lung cancer cell lines.
Lung Cancer.    impact factor:   1.401
1998;  21(3): 165-75

343:  Suzuki M, Kuwahara A.
Synergistic interaction between VIP-related peptides and bombesin on ion transport in guinea pig distal colonic mucosa.
Ann N Y Acad Sci.    impact factor:   1.381
2000;  921: 420-4

344:  Edwards GL, Power JD.
The role of brain-gut peptides in the control of sodium appetite.
Ann N Y Acad Sci.    impact factor:   1.381
1999;  897: 192-7

345:  Sharif M.
Mitogenic signaling by substance P and bombesin-like neuropeptide receptors in astrocytic/glial brain tumor-derived cell lines.
Int J Oncol.    impact factor:   1.381
1998;  12(2): 273-86

346:  Fruhwald MC, O'Dorisio MS, Cottingham SL, Qualman SJ, O'Dorisio TM.
Neuropeptides in developmental tumors of the central and peripheral nervous system.
Ann N Y Acad Sci.    impact factor:   1.381
1998;  865: 420-6

347:  Frankmann SP, Henninger J, Kruse MJ, Westerman K, Houpt TA.
c-Fos induction in the nucleus of the solitary tract of sodium-depleted rats by salt intake, peripheral bombesin, and the combination.
Ann N Y Acad Sci.    impact factor:   1.381
1997;  814: 292-4

348:  Bold RJ, Ishizuka J, Yao CZ, Townsend CM Jr, Thompson JC.
Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptors status.
Anticancer Res.    impact factor:   1.375
1998;  18(6A): 4051-6

349:  Suzuki S, Takiguchi S, Sato N, Kanai S, Kawanami T, Yoshida Y, Miyasaka K, Takata Y, Funakoshi A, Noda T.
Importance of CCK-A receptor for gallbladder contraction and pancreatic secretion: a study in CCK-A receptor knockout mice.
Jpn J Physiol.    impact factor:   1.351
2001;  51(5): 585-90

350:  Ishii H, Kinoshita E, Kimura T, Yakehiro M, Yamaoka K, Imoto K, Mori Y, Seyama I.
Point-mutations related to the loss of batrachotoxin binding abolish the grayanotoxin effect in Na(+) channel isoforms.
Jpn J Physiol.    impact factor:   1.351
1999;  49(5): 457-61

351:  Westermark T, Rantapaa-Dahlqvist S, Wallberg-Jonsson S, Kjorell U, Forsgren S.
Increased content of bombesin/GRP in human synovial fluid in early arthritis: different pattern compared with substance P.
Clin Exp Rheumatol.    impact factor:   1.348
2001;  19(6): 715-20

352:  Kamei J, Sasaki M, Zushida K, Morita K, Tanaka S.
Nociception and allodynia/hyperalgesia induced by intrathecal administration of fenvalerate.
Jpn J Pharmacol.    impact factor:   1.317
2001;  86(3): 336-41

353:  Darker JG, Brough SJ, Heath J, Smart D.
Discovery of potent and selective peptide agonists at the GRP-preferring bombesin receptor (BB2).
J Pept Sci.    impact factor:   1.311
2001;  7(11): 598-605

354:  Devin C, Bernad N, Cristau M, Artis-Noel AM, Heitz A, Fehrentz JA, Martinez J.
Synthesis and biological evaluation of C-terminal hydroxamide analogues of bombesin.
J Pept Sci.    impact factor:   1.311
1999;  5(4): 176-84

355:  Nyeki O, Rill A, Schon I, Orosz A, Schrett J, Bartha L, Nagy J.
Synthesis of peptide and pseudopeptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells.
J Pept Sci.    impact factor:   1.311
1998;  4(8): 486-95

356:  Lutz TA, Tschudy S, Rushing PA, Scharrer E.
Attenuation of the anorectic effects of cholecystokinin and bombesin by the specific amylin antagonist AC 253.
Physiol Behav.    impact factor:   1.285
2000;  70(5): 533-6

357:  Bungo T, Ando R, Kawakami S, Ohgushi A, Shimojo M, Masuda Y, Furuse M.
Central bombesin inhibits food intake and the orexigenic effect of neuropeptide Y in the neonatal chick.
Physiol Behav.    impact factor:   1.285
2000;  70(5): 573-6

358:  Thaw AK, Smith JC, Gibbs J.
Mammalian bombesin-like peptides extend the intermeal interval in freely feeding rats.
Physiol Behav.    impact factor:   1.285
1998;  64(3): 425-8

359:  Flynn FW.
Bombesin receptor antagonists block the effects of exogenous bombesin but not of nutrients on food intake.
Physiol Behav.    impact factor:   1.285
1997;  62(4): 791-8

360:  De Caro G, Polidori C, Menani JV, Johnson AK.
Bombesin affects the central nervous system to produce sodium intake inhibition in rats.
Physiol Behav.    impact factor:   1.285
1997;  63(1): 15-23

361:  Hayataka K, O'Connor MF, Kinzler N, Weber JT, Parker KK.
A bioactive peptide from the transmembrane 5-intracellular loop 3 region of the human 5HT1a receptor.
Biochem Cell Biol.    impact factor:   1.268
1998;  76(4): 657-60

362:  Pires OR Jr, Sebben A, Schwartz EF, Largura SW, Bloch C Jr, Morales RA, Schwartz CA.
Occurrence of tetrodotoxin and its analogues in the Brazilian frog Brachycephalus ephippium (Anura: Brachycephalidae).
Toxicon.    impact factor:   1.248
2002;  40(6): 761-6

363:  Brown MA, Hambe B, Furie B, Furie BC, Stenflo J, Stenberg LM.
Detection of vitamin K-dependent proteins in venoms with a monoclonal antibody specific for gamma-carboxyglutamic acid.
Toxicon.    impact factor:   1.248
2002;  40(4): 447-53

364:  Lipps BV, Khan AA.
Antigenic cross reactivity among the venoms and toxins from unrelated diverse sources.
Toxicon.    impact factor:   1.248
2000;  38(7): 973-80

365:  Brubacher JR, Lachmanen D, Ravikumar PR, Hoffman RS.
Efficacy of digoxin specific Fab fragments (Digibind) in the treatment of toad venom poisoning.
Toxicon.    impact factor:   1.248
1999;  37(6): 931-42

366:  Schwartz EN, Schwartz CA, Sebben A, Largura SW, Mendes EG.
Indirect cardiotoxic activity of the caecilian Siphonops paulensis (Gymnophiona, Amphibia) skin secretion.
Toxicon.    impact factor:   1.248
1999;  37(1): 47-54

367:  Daly JW, Padgett WL, Saunders RL, Cover JF Jr.
Absence of tetrodotoxins in a captive-raised riparian frog, Atelopus varius.
Toxicon.    impact factor:   1.248
1997;  35(5): 705-9

368:  Meloni F, Ballabio P, Pistorio A, Todarello C, Montoli C, Berrayah L, Meloni C, Grassi C, Aguayo SM.
Urinary levels of bombesin-related peptides in a population sample from northern Italy: potential role in the pathogenesis of chronic obstructive pulmonary disease.
Am J Med Sci.    impact factor:   1.217
1998;  315(4): 258-65

369:  Lesniewska V, Gregard A, Westrom B, Hedemann MS, Laerke HN, Kruszewska D, Pierzynowski SG.
The role of cholinergic and peptidergic pathways in the regulation of pancreatic exocrine function during postnatal development in pigs.
Exp Physiol.    impact factor:   1.17
2001;  86(3): 399-409

370:  Van de Wiele C, Dumont F, van Belle S, Slegers G, Peers SH, Dierckx RA.
Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging?
Nucl Med Commun.    impact factor:   1.165
2001;  22(1): 5-15

371:  Martinez A, Buchan AM, Lopez J, Sesma P.
Colocalization of numerous immunoreactivities in endocrine cells of the chicken proventriculus at hatching.
Histochem J.    impact factor:   1.161
2000;  32(5): 295-301

372:  Hide G.
Mammalian epidermal growth factor stimulates G-protein activity in Trypanosoma brucei.
Parasitol Res.    impact factor:   1.161
1998;  84(2): 143-6

373:  Wartenberg HC, Wartenberg JP, Urban BW.
Single sodium channels from human ventricular muscle in planar lipid bilayers.
Basic Res Cardiol.    impact factor:   1.148
2001;  96(6): 645-51

374:  Beales IL, Calam J.
Helicobacter pylori increases gastrin release from cultured canine antral G-cells.
Eur J Gastroenterol Hepatol.    impact factor:   1.142
2000;  12(6): 641-4

375:  Beales IL, Calam J.
Helicobacter pylori infection and tumour necrosis factor-alpha increase gastrin release from human gastric antral fragments.
Eur J Gastroenterol Hepatol.    impact factor:   1.142
1997;  9(8): 773-7

376:  Hanna MK, Kudsk KA.
Nutritional and pharmacological enhancement of gut-associated lymphoid tissue.
Can J Gastroenterol.    impact factor:   1.135
2000;  14 Suppl D: 145D-151D

377:  Nichols DH, Lovas S, Adrian TE, Miller CA, Murphy RF.
Peptides bind to eosinophils in the rat stomach.
Anat Rec.    impact factor:   1.111
1998;  250(2): 172-81

378:  Forsstrom T, Tuominen J, Karkkainen J.
Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS.
Scand J Clin Lab Invest.    impact factor:   1.107
2001;  61(7): 547-56

379:  Lippl F, Schusdziarra V, Allescher HD.
Effect of endomorphin on somatostatin secretion in the isolated perfused rat stomach.
Neuropeptides.    impact factor:   1.075
2001;  35(5-6): 303-9

380:  Merali Z, McIntosh J, Anisman H.
Role of bombesin-related peptides in the control of food intake.
Neuropeptides.    impact factor:   1.075
1999;  33(5): 376-86

381:  Zagorodnyuk V, Santicioli P, Turini D, Maggi CA.
Tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the human ileum.
Neuropeptides.    impact factor:   1.075
1997;  31(3): 265-71

382:  Williams CA, Fowler WL.
Substance P released in the rostral brainstem of cats interacts with NK-1 receptors during muscle pressor response.
Neuropeptides.    impact factor:   1.075
1997;  31(6): 589-600

383:  Aalto Y, Kjorell U, Henriksson R, Franzen L, Forsgren S.
Bombesin-like peptide is present in duct cells in salivary glands: studies on normal and irradiated animals.
Neuropeptides.    impact factor:   1.075
1997;  31(2): 167-73

384:  Chi HT, Hung DZ, Hu WH, Yang DY.
Prognostic implications of hyperkalemia in toad toxin intoxication.
Hum Exp Toxicol.    impact factor:   1.063
1998;  17(6): 343-6

385:  Iwasaki S, Iwabuchi Y, Okumura Y.
Histological and ultrastructural studies of the effects of tachykinins on protein secretion from the lingual epithelium and the lingual gland of the Tokyo daruma pond frog (Rana porosa porosa).
Arch Oral Biol.    impact factor:   1.04
1998;  43(6): 463-71

386:  Villaro AC, Rovira J, Bodegas ME, Burrell MA, Garcia-Ros D, Sesma P.
Immunocytochemical and ultrastructural characterization of endocrine cells in the larval stomach of the frog Rana temporaria tadpoles: a comparison with adult specimens.
Tissue Cell.    impact factor:   1.028
2001;  33(5): 462-77

387:  Maughfling EJ, Boden P, Hall MD.
Construction of chimeric human bombesin receptors to identify neuromedin B and gastrin-releasing peptide receptor binding sites.
Biochem Soc Trans.    impact factor:   .975
1997;  25(3): 455S

388:  Bufalari A, Ferri M, Sidoni A, Alberti P, Giustozzi G, Moggi L.
Pancreatic regeneration after subtotal distal resection in rats. Effects of bombesin and octreotide by the in vivo bromodeoxyuridine uptake technique.
Eur Surg Res.    impact factor:   .939
1999;  31(5): 412-8

389:  Marion-Audibert AM, Nejjari M, Pourreyron C, Anderson W, Gouysse G, Jacquier MF, Dumortier J, Scoazec JY.
[Effects of endocrine peptides on proliferation, migration and differentiation of human endothelial cells]
Gastroenterol Clin Biol.    impact factor:   .927
2000;  24(6-7): 644-8

390:  Seretis E, Gavrill A, Agnantis N, Golematis V, Voloudakis-Baltatzis IE.
Comparative study of serotonin and bombesin in adenocarcinomas and neuroendocrine tumors of the colon.
Ultrastruct Pathol.    impact factor:   .918
2001;  25(6): 445-54

391:  Li MZ, Masuko S.
Neuronal circuitry between the inferior mesenteric ganglion and lower intestine of the dog.
Arch Histol Cytol.    impact factor:   .883
1997;  60(4): 391-404

392:  Iishi H, Tatsuta M, Baba M, Yano H, Sakai N, Uehara H, Nakaizumi A.
Suppression by verapamil of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in wistar rats.
Chemotherapy.    impact factor:   .797
2001;  47(1): 70-6

393:  Baldi A, Groger AM, Esposito V, Di Marino MP, Ferrara N, Baldi F.
Neuroendocrine differentiation in non-small cell lung carcinomas.
In Vivo.    impact factor:   .794
2000;  14(1): 109-14

394:  Ishimaru H, Kageyama Y, Hayashi T, Nemoto T, Eishi Y, Kihara K.
Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases.
Acta Oncol.    impact factor:   .747
2002;  41(3): 289-96

395:  Aalto Y, Forsgren S, Kjorell U, Funegard U, Franzen L, Henriksson R.
Does bombesin-like peptide mediate radiation-induced anorexia and satiety?
Acta Oncol.    impact factor:   .747
1999;  38(8): 1099-102

396:  Lidegran M, Forsgren S, Dahlqvist A, Franzen L, Domeij S.
Short- and long-term effects of irradiation on laryngeal mucosa of the rat.
Acta Oncol.    impact factor:   .747
1999;  38(8): 1081-91

397:  Severini C, Falconieri Erspamer G, Erspamer V.
Transmitter release and uptake evoked by the amphibian skin alkaloid, pumiliotoxin-B (PTX-B), in the electrically stimulated mouse vas deferens preparation (MVD).
J Auton Pharmacol.    impact factor:   .735
1998;  18(6): 333-42

398:  Robert-Gangneux F, Creuzet C, Dupouy-Camet J, Roisin MP.
Involvement of the mitogen-activated protein (MAP) kinase signalling pathway in host cell invasion by Toxoplasma gondii.
Parasite.    impact factor:   .726
2000;  7(2): 95-101

399:  Han B, Logsdon CD.
Cholecystokinin induction of mob-1 chemokine expression in pancreatic acinar cells requires NF-kappaB activation.
Am J Physiol.    impact factor:   .718
1999;  277(1 Pt 1): C74-82

400:  Brimhall BB, Sikorski KA, Torday J, Shahsafaei A, Haley KJ, Sunday ME.
Syntaxin 1A is transiently expressed in fetal lung mesenchymal cells: potential developmental roles.
Am J Physiol.    impact factor:   .718
1999;  277(2 Pt 1): L401-11

401:  Squires PE, Meloche RM, Buchan AM.
Bombesin-evoked gastrin release and calcium signaling in human antral G cells in culture.
Am J Physiol.    impact factor:   .718
1999;  276(1 Pt 1): G227-37

402:  Yoshida H, Tsunoda Y, Owyang C.
Diazepam-binding inhibitor33-50 elicits Ca2+ oscillation and CCK secretion in STC-1 cells via L-type Ca2+ channels.
Am J Physiol.    impact factor:   .718
1999;  276(3 Pt 1): G694-702

403:  Percy WH, Warren JM, Brunz JT.
Characteristics of the muscularis mucosae in the acid-secreting region of the rabbit stomach.
Am J Physiol.    impact factor:   .718
1999;  276(5 Pt 1): G1213-20

404:  Kurjak M, Fritsch R, Saur D, Schusdziarra V, Allescher HD.
NO releases bombesin-like immunoreactivity from enteric synaptosomes by cross-activation of protein kinase A.
Am J Physiol.    impact factor:   .718
1999;  276(6 Pt 1): G1521-30

405:  Michaud D, Anisman H, Merali Z.
Capsaicin-sensitive fibers are required for the anorexic action of systemic but not central bombesin.
Am J Physiol.    impact factor:   .718
1999;  276(6 Pt 2): R1617-22

406:  Akiyama T, Hirohata Y, Okabayashi Y, Imoto I, Otsuki M.
Supramaximal CCK and CCh concentrations abolish VIP potentiation by inhibiting adenylyl cyclase activity.
Am J Physiol.    impact factor:   .718
1998;  275(5 Pt 1): G1202-8

407:  Huber A, Saur D, Kurjak M, Schusdziarra V, Allescher HD.
Characterization and splice variants of neuronal nitric oxide synthase in rat small intestine.
Am J Physiol.    impact factor:   .718
1998;  275(5 Pt 1): G1146-56

408:  Plaisancie P, Barcelo A, Moro F, Claustre J, Chayvialle JA, Cuber JC.
Effects of neurotransmitters, gut hormones, and inflammatory mediators on mucus discharge in rat colon.
Am J Physiol.    impact factor:   .718
1998;  275(5 Pt 1): G1073-84

409:  Grady T, Mah'Moud M, Otani T, Rhee S, Lerch MM, Gorelick FS.
Zymogen proteolysis within the pancreatic acinar cell is associated with cellular injury.
Am J Physiol.    impact factor:   .718
1998;  275(5 Pt 1): G1010-7

410:  Tao C, Yamamoto M, Mieno H, Inoue M, Masujima T, Kajiyama G.
Pepsinogen secretion: coupling of exocytosis visualized by video microscopy and [Ca2+]i in single cells.
Am J Physiol.    impact factor:   .718
1998;  274(6 Pt 1): G1166-77

411:  Chang CH, Chey WY, Erway B, Coy DH, Chang TM.
Modulation of secretin release by neuropeptides in secretin-producing cells.
Am J Physiol.    impact factor:   .718
1998;  275(2 Pt 1): G192-202

412:  Sbrissa D, Hajra A, Bitar KN.
Origin of molecular species of diacylglycerol induced by bombesin in smooth muscle cells from rabbit rectosigmoid.
Am J Physiol.    impact factor:   .718
1998;  275(1 Pt 1): G138-50

413:  Ehrlich K, Plate S, Stroff T, Gretzer B, Respondek M, Peskar BM.
Peptidergic and cholinergic neurons and mediators in peptone-induced gastroprotection: role of cyclooxygenase-2.
Am J Physiol.    impact factor:   .718
1998;  274(5 Pt 1): G955-64

414:  Hashmonai M, Szurszewski JH.
Effect of cerebroventricular perfusion of bombesin on gastrointestinal myoelectric activity.
Am J Physiol.    impact factor:   .718
1998;  274(4 Pt 1): G677-86

415:  Moran TH, Katz LF, Plata-Salaman CR, Schwartz GJ.
Disordered food intake and obesity in rats lacking cholecystokinin A receptors.
Am J Physiol.    impact factor:   .718
1998;  274(3 Pt 2): R618-25

416:  Nishino H, Tsunoda Y, Owyang C.
Mammalian bombesin receptors are coupled to multiple signal transduction pathways in pancreatic acini.
Am J Physiol.    impact factor:   .718
1998;  274(3 Pt 1): G525-34

417:  Pfeiffer F, Sternfeld L, Schmid A, Schulz I.
Control of Ca2+ wave propagation in mouse pancreatic acinar cells.
Am J Physiol.    impact factor:   .718
1998;  274(3 Pt 1): C663-72

418:  Cho WK, Mennone A, Boyer JL.
Intracellular pH regulation in bombesin-stimulated secretion in isolated bile duct units from rat liver.
Am J Physiol.    impact factor:   .718
1998;  275(5 Pt 1): G1028-36

419:  Schaffer K, Herrmuth H, Mueller J, Coy DH, Wong HC, Walsh JH, Classen M, Schusdziarra V, Schepp W.
Bombesin-like peptides stimulate somatostatin release from rat fundic D cells in primary culture.
Am J Physiol.    impact factor:   .718
1997;  273(3 Pt 1): G686-95

420:  Bragado MJ, Groblewski GE, Williams JA.
p70s6k is activated by CCK in rat pancreatic acini.
Am J Physiol.    impact factor:   .718
1997;  273(1 Pt 1): C101-9

421:  Schwartz GJ, Moran TH, White WO, Ladenheim EE.
Relationships between gastric motility and gastric vagal afferent responses to CCK and GRP in rats differ.
Am J Physiol.    impact factor:   .718
1997;  272(6 Pt 2): R1726-33

422:  Sbrissa D, Yamada H, Hajra A, Bitar KN.
Bombesin-stimulated ceramide production and MAP kinase activation in rabbit rectosigmoid smooth muscle cells.
Am J Physiol.    impact factor:   .718
1997;  272(6 Pt 1): G1615-25

423:  Lloyd KC, Amirmoazzami S, Friedik F, Chew P, Walsh JH.
Somatostatin inhibits gastrin release and acid secretion by activating sst2 in dogs.
Am J Physiol.    impact factor:   .718
1997;  272(6 Pt 1): G1481-8

424:  Furukawa T, Kimura O, Go S, Iwai N.
The effect of bombesin on syngeneically transplanted intestinal mucosa.
Transplant Proc.    impact factor:   .678
2002;  34(3): 1025-6

425:  Kimura O, Go S, Furukawa T, Iwai N.
Influence of bombesin on the intestinal mucosal immunologic response under immunosuppression.
Transplant Proc.    impact factor:   .678
2000;  32(6): 1269-71

426:  Todd WM, Kafrawy AH, Newton CW, Brown CE Jr.
Immunohistochemical study of gamma-aminobutyric acid and bombesin/gastrin releasing peptide in human dental pulp.
J Endod.    impact factor:   .668
1997;  23(3): 152-7

427:  Seeds EA, Spina D, Page CP.
The role of sensory nerves in propranolol-induced bronchial hyperresponsiveness in the guinea-pig.
Pulm Pharmacol Ther.    impact factor:   .622
1999;  12(1): 27-34

428:  Lipps BV.
Detection of nerve growth factor (NGF) in venoms from diverse source: isolation and characterization of NGF from the venom of honey bee (Apis melifera).
J Nat Toxins.    impact factor:   .619
2000;  9(1): 13-9

429:  Xie JT, Wang H, Attele AS, Yuan CS.
Effects of resibufogenin from toad venom on isolated Purkinje fibers.
Am J Chin Med.    impact factor:   .583
2000;  28(2): 187-96

430:  De Vincentis G, Scopinaro F, Varvarigou A, Ussof W, Schillaci O, Archimandritis S, Corleto V, Longo F, Delle Fave G.
Phase I trial of technetium [Leu13] bombesin as cancer seeking agent: possible scintigraphic guide for surgery?
Tumori.    impact factor:   .569
2002;  88(3): S28-30

431:  Scopinaro F, Varvarigou A, Ussof W, De Vincentis G, Archimandritis S, Evangelatos G, Corleto V, Pulcini A, Capoccetti F, Remediani S, Massa R.
Breast cancer takes up 99mTc bombesin. A preliminary report.
Tumori.    impact factor:   .569
2002;  88(3): S25-8

432:  Ku SK, Lee HS, Lee JH.
An immunohistochemical study of endocrine cells in the alimentary tract of the red-bellied frog, Bombina orientalis.
J Vet Med Sci.    impact factor:   .567
2000;  62(6): 589-94

433:  Muto N, Eguchi R, Akagi Y, Itoh N, Tanaka K.
Cholecystokinin stimulates ascorbic acid secretion through its specific receptor in the perfused stomach of rats.
Res Commun Mol Pathol Pharmacol.    impact factor:   .495
1998;  101(2): 127-36

434:  Lobasso S, Lippe C, Bellantuono V, Ardizzone C.
Action of physalaemin on the ionic transport across the frog skin.
Arch Physiol Biochem.    impact factor:   .479
1998;  105(4): 329-36

435:  Fortuno A, Ballaz S, Del Rio J, Barber A.
CCK-mediated response in the activation of 5-HT receptor types in the guinea-pig ileum.
J Physiol Biochem.    impact factor:   .385
1999;  55(2): 85-92

436:  Cho WK.
Role of the neuropeptide, bombesin, in bile secretion.
Yale J Biol Med.    impact factor:   .381
1997;  70(4): 409-16

437:  Asabe K, Tsuji K, Handa N, Kajiwara M, Suita S.
Immunohistochemical distribution of bombesin-positive pulmonary neuroendocrine cells in a congenital diaphragmatic hernia.
Surg Today.    impact factor:   .379
1999;  29(5): 407-12

438:  Chen LW, Hsu CM, Huang JK, Chen JS, Chen SC.
Effects of bombesin on gut mucosal immunity in rats after thermal injury.
J Formos Med Assoc.    impact factor:   .362
2000;  99(6): 491-8

439:  Kawahara K, Mikage M.
Studies on toad venom (3): effect of metals on the quality of toad venom torrefied on a metal plate.
Yakugaku Zasshi.    impact factor:   .238
2002;  122(1): 117-9

440:  Kawahara K, Mikage M.
Studies on toad venom (2): Examination of the drying processing method.
Yakugaku Zasshi.    impact factor:   .238
2000;  120(11): 1217-9

441:  Djanani AM, Kahler ChM.
Modulation of inflammation by vasoactive intestinal peptide and bombesin: lack of effects on neutrophil apoptosis.
Acta Med Austriaca.    impact factor:   .158
2002;  29(3): 93-6

442:  Diaz MD, Fioroni M, Burger K, Berger S.
Evidence of complete hydrophobic coating of bombesin by trifluoroethanol in aqueous solution: an NMR spectroscopic and molecular dynamics study.
Chemistry.    impact factor:   0
2002;  8(7): 1663-9

443:  Wong S, Tsui S, Kwan S.
Analysis of proprietary Chinese medicines for the presence of toxic ingredients by LC/MS/MS.
J Pharm Biomed Anal.    impact factor:   0
2002;  30(1): 161-70

444:  Krylov VN.
[The study of cardiotonic action of green frog poison Bufo viridis]
Zh Evol Biokhim Fiziol.    impact factor:   0
2002;  38(2): 173-6

445:  Kiehne K, Herzig KH, Folsch UR.
Differential activation of p42ERK2 and p125FAK by cholecystokinin and bombesin in the secretion and proliferation of the pancreatic amphicrine cell line AR42J.
Pancreatology.    impact factor:   0
2002;  2(1): 46-53

446:  Yamada K, Santo-Yamada Y, Wada E, Wada K.
Role of bombesin (BN)-like peptides/receptors in emotional behavior by comparison of three strains of BN-like peptide receptor knockout mice.
Mol Psychiatry.    impact factor:   0
2002;  7(1): 113-7, 6

447:  Bajo AM, Schally AV, Krupa M, Hebert F, Groot K, Szepeshazi K.
Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.
Proc Natl Acad Sci U S A.    impact factor:   0
2002;  99(6): 3836-41

448:  Tan CH, Holmes AB.
The synthesis of (+)-allopumiliotoxin 323B'.
Chemistry.    impact factor:   0
2001;  7(9): 1845-54

449:  Summers K, Clough ME.
The evolution of coloration and toxicity in the poison frog family (Dendrobatidae).
Proc Natl Acad Sci U S A.    impact factor:   0
2001;  98(11): 6227-32

450:  Wartenberg HC, Wartenberg JP, Urban BW.
Human cardiac sodium channels are affected by pentobarbital.
Eur J Anaesthesiol.    impact factor:   0
2001;  18(5): 306-13

451:  Li WI, Berman FW, Okino T, Yokokawa F, Shioiri T, Gerwick WH, Murray TF.
Antillatoxin is a marine cyanobacterial toxin that potently activates voltage-gated sodium channels.
Proc Natl Acad Sci U S A.    impact factor:   0
2001;  98(13): 7599-604

452:  Abiko T, Kimura Y.
Syntheses and effect of bombesin-fragment6-14 and its four analogues on food intake in rats.
Curr Pharm Biotechnol.    impact factor:   0
2001;  2(2): 201-7

453:  Marinov BS, Wang GK.
Redox properties of local anesthetics: A structural determinant of closed channel blockers in BTX-modified Na+ channels.
Membr Cell Biol.    impact factor:   0
2001;  14(4): 553-63

454:  Schally AV, Comaru-Schally AM, Nagy A, Kovacs M, Szepeshazi K, Plonowski A, Varga JL, Halmos G.
Hypothalamic hormones and cancer.
Front Neuroendocrinol.    impact factor:   0
2001;  22(4): 248-91

455:  Tatsuta M, Iishi H, Baba M, Narahara H, Uedo N, Yano H, Yamamoto R, Mukai M, Akedo H.
Induction by bombesin of peritoneal metastasis of gastric cancers induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
Gastric Cancer.    impact factor:   0
2001;  4(1): 14-9

456:  Ott J.
Pharmanopo-psychonautics: human intranasal, sublingual, intrarectal, pulmonary and oral pharmacology of bufotenine.
J Psychoactive Drugs.    impact factor:   0
2001;  33(3): 273-81

457:  Leong D, Bloomquist JR, Bempong J, Dybas JA, Kinne LP, Lyga JW, Marek FL, Nicholson RA.
Insecticidal arylalkylbenzhydrolpiperidines: novel inhibitors of voltage-sensitive sodium and calcium channels in mammalian brain.
Pest Manag Sci.    impact factor:   0
2001;  57(10): 889-95

458:  Wang GK, Quan C, Seaver M, Wang SY.
Modification of wild-type and batrachotoxin-resistant muscle mu1 Na+ channels by veratridine.
Pflugers Arch.    impact factor:   0
2000;  439(6): 705-13

459:  Larran Lopez J, Aparicio Patino J, Lopez Munoz A, Vilches Troya J.
[Effect of the neuropeptides bombesin and calcitonin on the growth of prostate cell lines, PC-3, DU 145, and LNCaP]
Actas Urol Esp.    impact factor:   0
2000;  24(10): 779-84

460:  Weldon PJ.
Avian chemical defense: toxic birds not of a feather.
Proc Natl Acad Sci U S A.    impact factor:   0
2000;  97(24): 12948-9

461:  McBride MC.
Bufotenine: toward an understanding of possible psychoactive mechanisms.
J Psychoactive Drugs.    impact factor:   0
2000;  32(3): 321-31

462:  Dumbacher JP, Spande TF, Daly JW.
Batrachotoxin alkaloids from passerine birds: a second toxic bird genus (Ifrita kowaldi) from New Guinea.
Proc Natl Acad Sci U S A.    impact factor:   0
2000;  97(24): 12970-5

463:  Guo YS, Townsend CM Jr.
Roles of gastrointestinal hormones in pancreatic cancer.
J Hepatobiliary Pancreat Surg.    impact factor:   0
2000;  7(3): 276-85

464:  Lawton DE, Simcock DC, Candy EJ, Simpson HV.
Gastrin secretion by ovine antral mucosa in vitro.
Comp Biochem Physiol A Mol Integr Physiol.    impact factor:   0
2000;  126(2): 233-43

465:  Yoshida T, Kunito H, Saijo N.
[Growth factor and signal transduction in lung cancer cell]
Nippon Rinsho.    impact factor:   0
2000;  58(5): 1023-30

466:  Gao C, Abe K.
Structure-activity relationships of sialogogic heptapeptides analogous to physalaemin.
Oral Dis.    impact factor:   0
2000;  6(3): 180-6

467:  Nagy A, Plonowski A, Schally AV.
Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.
Proc Natl Acad Sci U S A.    impact factor:   0
2000;  97(2): 829-34

468:  Calatayud S, Quintana E, Esplugues J, Barrachina MD.
Role of central oxytocin in the inhibition by endotoxin of distension-stimulated gastric acid secretion.
Naunyn Schmiedebergs Arch Pharmacol.    impact factor:   0
1999;  360(6): 676-82

469:  Trandaburu T, Ali SS, Trandaburu I.
Granin proteins (chromogranin A and secretogranin II C23-3 and C26-3) in the endocrine pancreas of amphibians.
Anat Anz.    impact factor:   0
1999;  181(6): 585-92

470:  Patacchini R, Bartho L, De Giorgio R, Lenard L Jr, Stanghellini V, Barbara G, Lecci A, Maggi CA.
Involvement of endogenous tachykinins and CGRP in the motor responses produced by capsaicin in the guinea-pig common bile duct.
Naunyn Schmiedebergs Arch Pharmacol.    impact factor:   0
1999;  360(3): 344-53

471:  Szepeshazi K, Halmos G, Schally AV, Arencibia JM, Groot K, Vadillo-Buenfil M, Rodriguez-Martin E.
Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs.
J Cancer Res Clin Oncol.    impact factor:   0
1999;  125(8-9): 444-52

472:  McIntosh J, Anisman H, Merali Z.
Short- and long-periods of neonatal maternal separation differentially affect anxiety and feeding in adult rats: gender-dependent effects.
Brain Res Dev Brain Res.    impact factor:   0
1999;  113(1-2): 97-106

473:  Akashiba T, Matsumoto K, Kosaka N, Saito O, Horie T, Nemoto N.
Multifocal peripheral bronchial carcinoid tumour.
Respirology.    impact factor:   0
1999;  4(2): 199-201

474:  Masclee AA, Lam WF, Lamers CB.
Effect of bombesin on esophageal motility in humans.
Dis Esophagus.    impact factor:   0
1999;  12(1): 54-9

475:  Trandaburu T, Ali SS, Trandaburu I.
Granin proteins (chromogranin A and secretogranin II C23-3 and C26-3) in the intestine of reptiles.
Anat Anz.    impact factor:   0
1999;  181(3): 261-8

476:  Resch-Sedlmeier G, Sedlmeier D.
Release of digestive enzymes from the crustacean hepatopancreas: effect of vertebrate gastrointestinal hormones.
Comp Biochem Physiol B Biochem Mol Biol.    impact factor:   0
1999;  123(2): 187-92

477:  Wang J, Jin W, Jin H, Zhou F.
[Determination of resibufogenin and cinobufagin in venenum Bufonis by HPLC]
Zhongguo Zhong Yao Za Zhi.    impact factor:   0
1998;  23(11): 651-3, 702

478:  Wang SY, Wang GK.
Point mutations in segment I-S6 render voltage-gated Na+ channels resistant to batrachotoxin.
Proc Natl Acad Sci U S A.    impact factor:   0
1998;  95(5): 2653-8

479:  Hampton LL, Ladenheim EE, Akeson M, Way JM, Weber HC, Sutliff VE, Jensen RT, Wine LJ, Arnheiter H, Battey JF.
Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice.
Proc Natl Acad Sci U S A.    impact factor:   0
1998;  95(6): 3188-92

480:  Jayawickreme CK, Jayawickreme SP, Lerner MR.
Generation of multiuse peptide libraries for functional screenings.
Methods Mol Biol.    impact factor:   0
1998;  87: 107-18

481:  Wada K, Wada E, Watase K, Yamada K, Ohki-Hamazaki H.
Bombesin, obesity, and social behavior.
Mol Psychiatry.    impact factor:   0
1998;  3(3): 204-6

482:  Abramov AV, Kolesnik IuM, Trzhetsinskii SD, Gancheva OV.
[Bombesin stimulates pancreatic beta-cell function in rats with experimental diabetes]
Biull Eksp Biol Med.    impact factor:   0
1998;  126(7): 33-5

483:  Linford NJ, Cantrell AR, Qu Y, Scheuer T, Catterall WA.
Interaction of batrachotoxin with the local anesthetic receptor site in transmembrane segment IVS6 of the voltage-gated sodium channel.
Proc Natl Acad Sci U S A.    impact factor:   0
1998;  95(23): 13947-52

484:  Meloni F, Brocchieri A, Ballabio PC, Tua A, Grignani G, Grassi GG.
Bombesin, calcium homeostasis and tumour growth.
Monaldi Arch Chest Dis.    impact factor:   0
1998;  53(4): 405-9

485:  Burghardt B, Kisfalvi K, Varga G, Papp M.
Agonists and antagonists of regulatory peptides as tools to study regulation of pancreatic exocrine secretion, cell proliferation and gene expression.
Scand J Gastroenterol Suppl.    impact factor:   0
1998;  228: 11-20

486:  Scher H, Miller YE, Aguayo SM, Johnson KJ, Miller JE, McCray PB Jr.
Urinary bombesin-like peptide levels in infants and children with bronchopulmonary dysplasia and cystic fibrosis.
Pediatr Pulmonol.    impact factor:   0
1998;  26(5): 326-31

487:  Gutser UT, Friese J, Heubach JF, Matthiesen T, Selve N, Wilffert B, Gleitz J.
Mode of antinociceptive and toxic action of alkaloids of Aconitum spec..
Naunyn Schmiedebergs Arch Pharmacol.    impact factor:   0
1998;  357(1): 39-48

488:  Shimidzu T, Itoh Y, Tatsumi S, Hayashi S, Ukai Y, Yoshikuni Y, Kimura K.
Blockade of voltage-sensitive sodium channels by NS-7, a novel neuroprotective compound, in the rat brain.
Naunyn Schmiedebergs Arch Pharmacol.    impact factor:   0
1997;  355(5): 601-8

489:  Barrachina MD, Martinez V, Wang L, Wei JY, Tache Y.
Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice.
Proc Natl Acad Sci U S A.    impact factor:   0
1997;  94(19): 10455-60

490:  Kent P, Plamondon H, Merali Z.
Pharmaco-ontogeny of bombesin's suppression of food intake and its attenuation by histamine H3 receptor agonists.
Brain Res Dev Brain Res.    impact factor:   0
1997;  102(1): 87-95

491:  Leger JP, Mathieson WB.
Effects of bombesin on behavioral thermoregulation in the bullfrog.
Brain Behav Evol.    impact factor:   0
1997;  50(5): 304-12

492:  Brown DR, O'Grady SM.
Regulation of ion transport in the porcine intestinal tract by enteric neurotransmitters and hormones.
Comp Biochem Physiol A Physiol.    impact factor:   0
1997;  118(2): 309-17

493:  Szepeshazi K, Schally AV, Halmos G, Lamharzi N, Groot K, Horvath JE.
A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers.
Proc Natl Acad Sci U S A.    impact factor:   0
1997;  94(20): 10913-8

494:  Kang JX, Li Y, Leaf A.
Regulation of sodium channel gene expression by class I antiarrhythmic drugs and n - 3 polyunsaturated fatty acids in cultured neonatal rat cardiac myocytes.
Proc Natl Acad Sci U S A.    impact factor:   0
1997;  94(6): 2724-8


Responsed in 3312 milliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005